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iAbstract
Nucleoside 5’-triphosphates (NTPs) are ubiquitous throughout the natural world.
As such investigations into their interactions within organisms is essential. Cur-
rently, commercially available NTPs are expensive due to the synthetic challenges
associated with the formation of phosphoanhydride bonds.
Chemo-enzymatic approaches to NTP synthesis are readily applicable to natu-
rally occuring NTPs, as such these methods have gained traction over recent years.
We have investigated a nucleoside diphosphate kinase (NDPK H122G) mediated
chemo-enzymatic method for the phosphorylation of nucleoside- 5’-diphosphates
(NDPs), using phosphoimidazole as a phosphoryl donor. We developed a synthetic
route and a purification procedure, which allowed for the production and partial
purification of phosphoimidazole using inexpensive chemical precursors. The opti-
misation investigations undertaken during the development of the phosphoimidazole
synthetic protocol resulted in an increase in phosphoimidazole production from 45%
to 55% in the crude reaction solution. Optimisation of the purification procedure
led to the production of phosphoimidazole of 98% purity.
NDPK H122G catalysed phosphorylation reactions of adenosine 5’-diphosphate
(ADP), were investigated over a range of conditions. The effect of both acetoni-
trile and imidazole impurities on the total conversion of ADP to adenosine 5’-
triphosphate (ATP) was investigated. It was found that both acetonitrile and imi-
dazole impurities prompted a decrease in the % conversion to ATP of 17% and 22%,
respectively. The effect of phosphoimidazole concentration on the initial rate of
phosphorylation and total % conversion after 24 h was also investigated. The initial
rate of phosphorylation and the % conversion to ATP after 24 h, were both found
to increase with the initial concentration of phosphoimidazole. Initial phosphoimi-
dazole concentrations of 5, 10, 20 and 50 mM were investigated; total % conversion
to ATP after 24 h was found to be 12%, 14%, 30% and 43%, the initial rate of
phosphorylation was 0.752 × 108, 1.263 × 108, 1.627 × 108 and 2.588 × 108 M s−1,
respectively.
The kinetics of the NDP phosphorylation reactions were monitored using high
performance liquid chromatography (HPLC). Phosphorylation of ADP was moni-
tored on a SUPELCOSIL-LC-18-T reversed-phase analytical column, while GDP
phosphorylation was monitored on a SIELC-Primesep SB mixed mode analytical
column. Protocols were developed for both of the columns to ensure that the nu-
cleotides had significant retentions times and the peaks were well separated with
little tailing.
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1 INTRODUCTION 1
1 Introduction
This thesis discusses the use of a chemo-enzymatic route towards the synthesis of
NTPs via the use of a kinase enzyme. Through the use of inexpensive chemical
precursors, our aim was to develop and optimise a simple, cost-efficient chemo-
enzymatic method to synthesize NTPs and their analogues. Thus avoiding difficult
and complex synthetic challenges and costs.
1.1 Nucleotides in Biological Systems
Nucleotides and in particular NTPs are ubiquitous throughout the natural world,
and they are integral to many of the most fundamental processes in living sys-
tems. From the inheritance of genetic information through nucleic acids such as
DNA (Figure 1), to the phosphoryl transfer of the γ-phosphate of ATP (Figure 2),
which releases the chemical energy necessary for thermodynamically unfavourable
processes such as cellular construction and maintenance, NTPs play a vital role.1
Figure 1 Structure of a three nucleoside strand of DNA
The abundance of nucleotides in nature, means that research into their interac-
tions within organisms is essential. Currently, commercial NTPs and their available
analogues are expensive owing to the synthetic difficulties associated with the for-
mation of phosphoanhydride bonds2 .
Figure 2 Structure of ATP: green moiety - triphosphate group, red moiety -
deoxyribose sugar, blue moiety - adenosine nucleobase
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1.1.1 Glycosylation Processes
In nature all cells have an array of covalently bound monosaccharides and oligosac-
charides, these sugar moieties are commonly referred to as glycogens.3 Glycogens
can be found on the surface of cells and macromolecules mediating; cell-cell, cell-
matrix and cell-molecule interactions, as such they are critical to the development of
multicellular organisms. Glycogens often conjugate with other biological molecules
such as protein and lipids, thus forming glycoproteins and glycolipids. Glycoproteins
are predominantly found in the cytoplasm and nucleus of cells, where they serve as
regulatory switches.3
Common classes of eukaryotic conjugate glycogens are categorised based on the
linkage between the glycogen and the conjugate unit. Proteins in glycoproteins are
covalently bound to the glycogens molecules via O- or N- linkages to the polypep-
tide backbone.3 Most conjugate glycogens, such as glycoproteins, are produced in
the endoplasmic reticulum (ER) and the golgi apparatus, new proteins are produced
in the ER and undergo glycosylation, a post translational modification which co-
valently binds glycogens (usually monosaccharides) to the protein.4 Glycosylation
reactions use activated forms of monosaccharides, typically in the form of nucleotide
sugars which act as high energy donors, these reactions are catalysed by glycosyl-
transferase enzymes.3 The process of forming activated nucleotide sugars requires a
NTP, typically UTP or GTP, and a monosaccharide with a phosphate group bound
to the anomeric carbon.5 There are two methods used to make these nucleoside sug-
ars, (1) monosaccharide-1-phosphate utilises a kinase enzyme, forming an activated
sugar nucleotide and a inorganic pyrophosphate.5 (2) nucleotide sugars can also be
formed by the exchange of the nucleotide from one sugar to another, an example of
this is the leloir pathway.
The leloir pathway (Scheme 1) is responsible for the conversion of UDP-galactose
to UDP-glucose, it also produces the more metabolically useful glucose-1-phosphate
from β-D-galactose6.7 The pathway consists of four enzymatic reactions; in the first
reaction galactose mutarotase, catalyses the epimerisation of D-galactose from the
β to the α form.7 α-D-galactose is phosphorylated by a galactokinase (ATP depen-
dant) in the second reaction, resulting in the production of galactose-1-phosphate.7
The third enzymatic reaction uses galactose-1-phosphate uridylyltransferase, to me-
diate the transfer of UMP from UDP-glucose to galactose-1-phosphate, producing
glucose-1-phosphate and UDP-galactose. The fourth and final reaction, converts
UDP-galactose to UDP-glucose via UDP-galactose 4-epimerase.8 The UDP-glucose
produced is a high energy nucleotide sugar, which can act as a donor to form conju-
gate glycogens such as glycoproteins, an enzymatic reaction mediated by glycosyl-
transferase.
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Scheme 1 Schematic showing the four enzyme catalysed reactions with make up the
leloir pathway. 1 Conversion of β-D-galactose to the α form. 2 Kinase mediated reaction
using ATP as a phosphate donor to produce galactose-1-phosphate. 3 Reaction between
UTP-glucose and galactose-1-phosphate producing glucose-1-phosphate and
UDP-galactose. 4 UDP-galactose is epimerised to produce UDP-glucose.
1.2 Kinase Enzymes
Protein kinases are one of the largest classes of enzyme, there are estimated to be
over 2000 protein kinases in the vertebrate genome, which are involved in a plethora
of biochemical processes.9 Humans have 518 protein kinase genes, which account for
∼ 1.7 % of all human genes.10
Kinases catalyse the transfer of a phosphoryl group from a phosphate donor to a
substrate, thus phosphorylating the substrate.11 Phosphorylation is one of the most
prevalent post-translational modifications found in the cell. Protein kinases regulate
a wide range of biochemical processes, including the metabolism of both lipids and
proteins, neurotransmitter biosynthesis, DNA transcription and replication as well
as cell differentiation.9
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Figure 3 a structure of NTP, b structure of NDP. Green moiety is the phosphate group,
the red moiety is the ribose sugar and the blue moiety is the nucleobase
Kinases are ATP-dependant phosphotransferases that catalyse the transfer of the
γ- phosphoryl group of the ATP. There are several varieties of categories of protein
kinases; (1) serine/threonine, (2) tyrosine and (3) histidine.12 Both serine/threonine
and tyrosine protein kinases are primarily used for signal transduction, they catalyse
phosphorylation by transferring the phosphoryl group to the hydroxyls of serine,
threonine or tyrosine.12 Histidine protein kinases (NDPK) catalyse the transfer of
the phosphoryl group onto a histidine residue, which then transfers the phosphoryl
group to an NDP. The most common NTP used for phosphorylation by nature is
adenosine triphosphate (ATP), but NDPKs are promiscuous and as such they are
capable of utilising all NTPs irregardless of nucleobase as phosphoryl donors.12
There are myriad histidine protein kinases which differ in size, substrate speci-
ficity, and subunit composition, despite these differences all histidine protein kinases
known to date share at least 40% of their genetic sequence and contain a homolo-
gous catalytic core, thus implying that similar phosphorylation mechanisms will be
employed by all protein kinases,13 eukaryotic enzymes tend to present as hexamers
(trimer of dimers with D3 dihedral symmetry), while a number of bacterial enzymes
are tetramers (pair of dimers with D2 pyrimidal symmetry).14 The dimers which
make up the tertiary structure of the NDPK enzyme are all identical, and form the
conserved catalytic core of NDPK enzymes.14
The conserved catalytic core of protein kinases consists of two regions separated
by a large cleft , a N -region, used for the binding of ATP, and a larger C -region
which is responsible for catalysis and substrate binding (Figure 4)13.15 The N -region
is made up of a 5-strand antiparallel β-sheet and a α helix. The α and β-phosphate
groups of ATP bind to a phosphate anchor, situated between β1 and β2 in the
N-region.15
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Figure 4 Conserved catalytic core of NDPK, made in MacPyMOL using PDB entry
1NDK.16
The C -region consists of four β strands and a two α helices.15 The arrangement
of the β sheets and α helices forms an α-β sandwich (ferredoxin fold), a motif
commonly found in nature. The two α helices connect β1 to β2 and β3 to β4,
respectively. The geometrical conformation of the β α β β α β arrangement results
in the formation of a hydrophobic core, which is highly conserved between all known
NDPKs. These two regions not only provide and position the essential amino acids
needed to catalyse the phosphoryl transfer reaction but also coordinate to Mg2+
ions, which assist ATP binding and expedite the phosphoryl transfer reaction.15
Figure 5 NDPK binding ATP in the catalytic core with Mg2+ cations in preparation for
phosphoryl transfer, adapted from15
The first Mg2+ optimises the positioning of the γ-phosphoryl group of ATP,
Mg2+ also neutralises charges on the γ-phosphate group thus facilitating nucleophilic
attack.15 The second Mg2+ ion is bound to amino acid residues asparagine and
aspartic acid and a water molecule. It is thought to act as a lewis acid, stabilising
the negative charge which develops on the oxygen between γ and β phosphate groups
during the transition state.17
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1.2.1 Nucleoside Diphosphate Kinase
Nucleoside diphosphate kinase (NDPK) enzymes catalyse the reversible transfer
of a γ-phosphoryl group from a nucleoside 5’-triphosphate (NTP) to a nucleoside
5’-diphosphate (NDP), via a covalent intermediate.18 NDPKs utilise a ’ping-pong’
mechanism to bring about the phosphorylation of the NDP substrate, a histidine
group in the NDPK active site is phosphorylated by the NTP.19 The phosphoryl
group is subsequently transferred onto a NDP molecule (Scheme 2).20
Scheme 2 NDPK ’ping-pong’ mechanism. Adapted from15
1.3 Methods of Nucleotide Synthesis
Nucleotides are difficult to synthesis, purify and store owing to a range of factors.
Firstly, one of the major challenges to the production of NTPs and their analogues
lies in the extensive and laborious purification procedures that are necessary to sep-
arate the complex crude reaction mixture of nucleotides (NMP, NDP and NTPs)
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and by-products (predominantly inorganic phosphates) that often arise from phos-
phorylation procedures.
Nucleotides and inorganic phosphate by-products often have similar characteristics,
thus making the isolation of nucleotides and their analogues particularly difficult,
and so purification of the nucleotides via chromatography remains a limiting step,
due to crude reaction mixtures being contaminated with a variety of anionic by-
products.21
NTPs have been shown be relatively stable in aqueous solutions at neutral pH.22
The rate of spontaneous hydrolysis of both ATP and ADP appears to be insensitive
to pH changes in the neutral range.23 Stockbridge and Wolfenden found that half-
life for the spontaneous hydrolysis of ATP4− when bound to Mg2+ was 17.5 days at
25 ◦C.24
In this section both the current chemical synthetic methods and chemo-enzymatic
methods of nucleotide synthesis will be discussed in detail. These examples will serve
to illustrate some of the challenges which are commonly found in NTP production.
After which, this section will focus on the use of imidazole to rescue activity of
genetically modified NDPKs, and how the reverse of this reaction can be utilised as
a chemo-enzymatic route towards nucleotides.
1.3.1 Chemical Synthesis
Nucleoside triphosphates, are rich with polar functional groups, it is this essential
polarity which determines and controls the molecular recognition properties of bio-
logical systems. It is this essential polarity which makes chemical synthesis methods
so laborious. Chemical synthesis requires dry reaction conditions and, due to the
polarity of the NTPs they are not soluble in organic solvents. To counter this, alky-
lammonium salts are used to aid solubility. Alkylammonium salts are extremely hy-
groscopic, to the point of deliquescence, thus increasing the chance of water ingress
into reactions and destroying reagents.
There are a variety of chemical synthesis methods that have been used in the
production of NTPs, this report will look in detail at solution-phase syntheses,
concentrating on syntheses via nucleophilic attack of pyrophosphate on activated
NMPs. The use of solid-supports in the synthesis of nucleoside 5’-triphosphates,
has become more prevalent in recent years and as such a section on solid-phase
synthesis of nucleotides has been included for completeness.
1.3.1.1 Solution-Phase Synthesis of Nucleoside Triphosphates .
The most common method of chemical synthesis of nucleoside 5’-triphosphates
utilises the nucleophilic attack of pyrophosphate on activated NMPs, the discon-
nection for this reaction is shown in Figure 6. text
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Figure 6 Disconnection for nucleophilic attack of pyrophosphate on activated NMPs
These reactions require the use of pyrophosphate salts , such as tri-n- butylam-
monium pyrophosphate, which are commercially available. The activated NMPs are
not available commercially and so must be prepared. This section will discuss NTP
formation via the nucleophilic attack of pyrophosphate on firstly phosphoridichloro-
date intermediate, then phosphoramidate intermediate.
1.3.1.1.1 NTP Formation via Phosphorodichloridate Intermediate
Nucleosides were successfully reacted with phosphorus oxychloride to form phos-
phorodichloridate intermediates by Yoshikawa’s group in 1967, (reaction is 5’ selec-
tive) they achieved this by using trialkylphosphate solvents, typically trimethyl- or
triethylphosphate. The rate of phosphorylation is increased in trialkyphosphate sol-
vents, unlike earlier solvents trialkyphosphate is able to dissolve both the nucleoside
and the reactive reagents25.26 Ludwig utilised Yoshikawa’s method for the forma-
tion of phosphorodichloridate intermediates, and adapted it to create a three-step,
one-pot synthesis method for NTPs, which is one of the most prevalent chemical
methods for NTP synthesis. Once produced, the phosphorodichloridate intermedi-
ate was reacted with tributylamine and a 5-fold excess of bis(tris-n-butylammonium)
phosphate in dry DMF for 1 minute, leading to the formation of a cyclic alkyl
trimetaphosphate intermediate (15), which is then hydrolysed resulting in the pro-
duction of NTPs, ATP produced by this method typically gives moderate to low
yields21.27
Scheme 3 Scheme of the three-step, one-pot synthesis devised by Ludwig to produce
NTPs, this scheme relates to ATP specifically.
Adenosine 5’-triphosphate (2) produced as the major product when there is a
large excess of POCl3 and tris-n-butylammonium. Currently, the suggested mecha-
nism utilises a psuedo-ATP intermediate (16), which undergoes a rearrangement to
form the cyclic alkyl trimetaphosphate intermediate (15) shown in Scheme 326.28
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Figure 7 Psuedo-ATP Intermediate, rearranges to form the cyclic intermediate shown
in Scheme 3
In 2010 Gillerman and Fischer used 1H decoupled 31P NMR to study the products
formed during ATP synthesis, AMP was found to be a major by-product formed via
the reaction of the phosphorodichloridate intermediate and residual water.29 POCl3
and DMF can react together to form the Vilsmeier reagent, which can then go on
to react with either pyrophosphate or the 2’- and 3’-OH groups of the cyclic alkyl
trimetaphosphate intermediate (15), to produce the by-products shown in figure
8.29
Figure 8 By-products formed via the reaction of the Vilsmeier reagent, in the Ludwig
Scheme for NTP synthesis
Due to the ease of the Ludwig procedure (one-pot reaction,unprotected nucle-
osides and relatively short reaction times), it remains one of the most prevalent
methods of NTP synthesis despite only moderate yields.
1.3.1.1.2 NTP Formation via Phosphoramidate Intermediate .
NTPs can be synthesised via nucleophilic substitution at a nucleoside 5’- phos-
phoramidate intermediate by inorganic pyrophosphate. Initial work into the use of
phosphoramidate intermediates for NTP synthesis concentrated on the use of DCC
in pyridine to activate nucleoside 5’-monophosphates, this resulted in the formation
of a complex array of by-products including mono-, di- and inorganic polyphos-
phates, which were formed in addition to the desired NTP21.26 Two major innova-
tions of the method of AMP activation by DCC have resulted in the development
of this method into a practical protocol. Firstly, the introduction of morpholine
into the first step of the reaction, enabled the formation of phosphoramidate in-
termediates. The second innovation came with the discovery that triphosphates
disproportionate in pyridine, thus NTPs would reach a peak concentration then de-
compose into NDPs. Moffat discovered that NTPs did not disproportionate in other
solvents such as DMSO (dimethyl sulfoxide), Scheme 4 shows the original synthetic
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pathway for ATP via this procedure, yields of between 73 -80 % were obtained for
NTPs made via this method26.30
Scheme 4 Reaction scheme of Moffat and Khorana ATP synthesis protocol using a
phosphoramidate intermediate30
Phosphoroimidazolidates are phosphoramidate intermediates, first utilised by
Hoard and Ott in the production of dNTPs.26,31 The nucleoside monophosphates are
activated by 1,1’-carbonyldiimidazole (CDI) in DMF (Scheme 5 ), yields ranged from
20 -70% depending on the dNTP being produced. 26,31 The use of this method for the
synthesis of NTPs initially had some issues as CDI and the activated NMPs reacted
to form cyclic carbonate impurities, which were carried through to the triphosphate
products.26 The carbonyl group can be removed via the use of ammonia.
Scheme 5 Reaction scheme of Hoard and Otts’ dNTP synthesis protocol, which was the
first method to utilise phosphoroimidazolidates as phosphoramidate intermediates26,31
Metal ions have been coordinated to phosphoroimidazolidates, this results in an
increase in the electrophilicity of the phosphoroimidazolidate. ATP (16) was synthe-
sised from 8-quinolyl phosphate using a metal mediated method.26 The intermediate
27 was activated by CuCl2 in DMSO, 16 was produced with a yield of 77%.
32
Scheme 6 Metal mediated synthesis of ATP, copper ions increase the electrophilicity of
the phosphoramidate intermediate
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1.3.1.2 Solid-Phase Synthesis of Nucleoside Triphosphates .
Solid-phase synthesis was first used in the 1960s, when the Merrifield method
was used to synthesise a tetrapeptide using a chloromethylated coploymer of styrene
and divinylbenzene.33 Solid-phase synthesis allows for reaction equilibriums to be
pushed towards completion via the use of excess reagents.21 Reaction products are
anchored onto a solid insoluble support, which makes purification of the crude re-
action mixture much simpler as soluble by-products and excess reagents may be
removed via filtration.21,34 The loading capacity of the support (number of binding
sites per gram of support), is an important feature of the support bead. Linkers are
often used to bond the reagent to the support, this is done to increase the ease of
product recovery by providing an easily cleaved bond.21
Controlled pore glass (CPG) and polystyrene (PS) are the two most common
forms of insoluble solid support, used in nucleotide synthesis. CPG is a nonswelling
insoluble material which contains large pores where nucleotide synthesis can oc-
cur.21 PS beads are highly crosslinked and exhibit hydrophobic properties, as such
they can be used for nucleotide synthesis.21 The use of insoluble beads gives het-
erogeneous reaction conditions, which can give rise to non-linear reaction kinetics
and inefficient coupling rates both of which are disadvantageous to effective nu-
cleotide synthesis.21 Soluble polymer-supported synthesis of nucleotides allows for
the easy separation of by-products and product, while maintaining homogeneous
reaction conditions, the two most widely used polymer-supports are poly(vinyl al-
cohol) (PVA) and poly(ethylene glycol) (PEG).21
1.3.1.2.1 NTP Formation with Sugar Moiety Bound to the Support
The Gaur group adapted Ludwig’s three-step, one-pot method in the early 1990s
to make it suitable for solid-phase synthesis.21 The method (Scheme 7) used a succin-
imide linker attached to an aminopropyl-CPG to synthesis 2’-O-methylribonucleoside
5’-triphosphates.35 All 2’-O-methylribonucleoside 5’-triphosphates produced achieved
yields of between 60-65%, the resulting NTP analogues where removed from the sup-
port via the use of hot aqueous ammonia.35
Scheme 7 Scheme of the three-step, one-pot synthesis adapted by the Gaur group for
solid-phase synthesis of NTPs
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The Meier group devised a solid state method for the synthesis of NTPs, via
the use of cycloSal-phosphate triesters as active ester reagents.21 The method used
utilised three distinct steps (Scheme 8), firstly the 2’-O-succinyl-cycloSal-nucleotides
(36, 37) were attached to aminomethyl-PS (38) via an amide bond.36 Conversion of
the immobilised 2’-O-succinyl-cycloSal-nucleotides to NTPs (41, 42) required the
use of a reactive nucleophile. The pyrophosphate nucleophile was prepared via ion
exchange of phosphoric acid, Na2H2P2O7, using an ion-exchange resin; the product
of which was titrated with [(nBu)4N]OH, to form the tetra-n-butyl ammonium salt
([(nBu)4]H2P2O7).
36 The resin (39, 40) and the nucleophilic pyrophosphate salt
were both rigorously dried, as the presence of water can result in the formation of
unwanted by-products.36 Removal of the produced salicyl alcohols and the excess
pyrophosphate from the polymer bound dNTPs was done via washing.36 Nucleoside
triphosphates 39 and 40 were both cleaved from the solid support via the use of hot
aqueous ammonia, the resulting products 41 and 42 had purities of 79% and 90%,
respectively.36
Scheme 8 Scheme of the three-step protocol developed by the Meier Group for the
solid-phase synthesis of NTPs
1.3.1.2.2 NTP Formation with Base Moiety Bound to the Support
In 2009, Peyrottes group devised a method for the synthesis of dCTP (54) and
CTP (55) via the use of a PEG soluble support (Scheme 9).21,37 Nucleosides 43
and 44 were bound to the soluble PEG support by a basolabile succinimide linker,
which reacted with the exocyclic amino group of the nucleobase.37,38 The % yield
of 46 and 47 was 87% and 83% respectively, both reactions gave a conversion rate
of 100%. The phosphorylation of the two NMPs; 48 and 49 was done using Hoards
method which requires the activation of NMPs via CDI to generate a phospho-
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ramidate intermediate.31,37 The phosphoramidate intermediate (50 or 51) was then
condensed with inorganic pyrophosphate, resulting in the formation of the desired
NTP derivative (52 or 53).37 The crude NTPs (54 and 55) produced gave yields of
70% and 90%, respectively. The purity of the crude products was determined via
HPLC, 54 had a purity of 84% and 55 a purity of 76%.37
Cleavage of the basolabile succinimide linker during the final step of the reaction
resulted in the formation of succinimide.39 The presence of succinimide and phos-
phate salts as by-products resulted in two purification steps, reverse phase HPLC
and dialysis.38,39
In 2018, the Peyrottes group investigated the effect of using a carboxylethoxy
linker instead of a succinimide linker.39The linker anchoring the nucleoside to the
soluble PEG support must have a carboxylic acid group to allow the formation of an
amide bond between the exocyclic amine of the nucleobase and the linker.39 To avoid
the formation of by-products, such as succinamide from the succinimide linker, the
bond between PEG and the linker must be stable throughout both phosphorylation
and the cleavage reaction. Work done by Ho¨lzl et al suggested that an ether bond
would be stable throughout the synthesis of the NTPs, as such a carboxylethoxy
linker was used.39,40
The use of the carboxylethoxyl linker instead of the succinimide linker, eliminated
the need for the dialysis step of the purification procedure thus reducing both the
complexity and the time required for the synthesis of 50 and 51.39
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Scheme 9 Scheme for the synthetic protocol devised by the Peyrottes group for the
synthesis of dCTP (54) and CTP (55)
1.3.2 Chemo-Enzymatic Synthesis
Chemo-enzymatic approaches to NTP synthesis are often readily applicable to nat-
urally occurring NTPs, especially if the product can be used as part of a crude
mixture, when it can be coupled to another enzyme system for immediate use. In
2003, work done by the Davisson group combined chemical and enzymatic pro-
cesses to produce dNTPs, the same enzymatic process was able to be used for all
of the dNTPs produced, regardless of nucleobase due to the promiscuity of NDPK
enzymes41.42 The production of NTPs utilised pyruvate kinase for the phosphory-
lation reaction, with PEP serving as the phosphate donor.
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Scheme 10 Scheme showing pyruvate kinase controlled synthesis of NTPs
1.3.2.1 NDPK Mediated NTP Synthesis .
NDPKs react via a ‘ping-pong’ type mechanism allowing the transfer of the phos-
phoryl group from NTPs to NDPs. In the production of NTPs, it is ATP which acts
as the phosphoryl donor. The histidine residue in the active site is phosphorylated
during the ‘ping’ step of the mechanism, at this stage the excess ATP is washed
away. The phosphorylated NDPK is then exposed to the substrate NDP, the phos-
phoryl group is transferred to the NDP during the ‘pong’ step of the mechanism,
after which the reaction solution is subjected to centrifugation and the new NTP is
collected. The use of ATP as the excess phosphoryl donor is one of the most pro-
hibitive factors to this procedure, ATP is a very expensive reagent and at present is
it washed away after the ping step and cannot be recovered.
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Scheme 11 Scheme showing the WT-NDPK mediated synthesis of NTP
1.3.2.1.1 Genetically Modified NDPK for NTP Synthesis .
In the late 1990’s Herschlag, began investigating whether a small molecule nucle-
ophile, such as imidazole could rescue activity of a mutated enzyme. The genetically
modified enzyme chosen was H122G, a site-directed mutant of NDPK in which the
His residue at position 122 had been changed to a Gly residue.43
Crystals of H122G in the presence of ATP were grown and were found to be very
similar in structure to WT-NDPK crystal structures, they were also found to have
the same space group as crystals grown with ADP·AlF3 which is the transition state
analogue. 43 This ablation of the His 122 residue has little effect on the surrounding
residues, with the main-chain conformation of adjacent amino acid residues in stand
β4 remaining unchanged.43 In WT-NDPK His 122 hydrogen bonds to Glu 133, se-
curing the position of the His group into the correct orientation. In the H122G
NDPK mutant, Glu 133 maintained its orientation despite the loss of the hydrogen
bond from the His residue, this is thought to be due to an interaction between the
carboxylate group of 133 Glu and the hydroxyl group of 124 Ser.43 These studies
found that in the absence of the His residue ATP dephosphorylation could be res-
cued by the presence of imidazole, with the k cat/KM value 50 times lower than the
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WT-enzyme at ATP saturation.43
Scheme 12 Herschlag’s work on using imidazole to rescue activity of the H122G NDPK
mutant
Rescuing activity of the mutated enzyme with imidazole produces ADP (61) and
PIm (62); due to the principle of microscopic reversibility this is a reversible reaction.
Under Herschlag’s conditions imidazole (60) is in excess and so the equilibrium
is pushed far towards the right (Figure 9), thus if 62 could be provided to the
NDPK in excess then this could potentially allow for NTP generation, using a cheap
phosphoryl donor such as PIm. This concept forms the core basis of this MSc project.
Figure 9 Equation showing the potential reversibility of Im rescue of NDPK activity.
Enzymatic Scheme 13 below, shows the synthesis of 62 and how it can poten-
tially be exploited as a phosphoryl donor in the NDPK reaction. The synthesis
and subsequent optimisation of a synthetic route towards phosphoimidazole will be
discussed in detail in Section 3.
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Scheme 13 Mutant NDPK scheme which allows the generation NTPs, using a cheap
phosphoryl donor
1.4 Biocatalysis for Cofactor Regeneration
In recent years biocatalysis as a synthetic route, has become more prevalent in both
academia and industry. While some enzymes (hydrolases) operate without the use of
cofactors, most enzymes that carry out complex chemical reactions require a range
of cofactors. Some cofactors such as, flavins and pyridoxal phosphate are bound
tightly to the enzyme active site and remain in place throughout the catalytic cycle,
these cofactors are self-regenerating and as such impart no economic burden onto
the use of these enzyme in biocatalysis. Cofactors such as ATP and nicotinamide
(NADPH) are dissociable, and work by providing functional groups that are trans-
ferred to substrate molecules, as such these cofactors must be used in stoichiometric
amounts. The financial cost of these cofactors prevents them from being used stoi-
chiometrically and instead they must be regenerated in situ 44 . Regeneration can be
done in one of three ways via; a coupled enzyme system, a coupled substrate system
or electrochemically. When compared with enzyme-coupled regeneration, electro-
chemical strategies have been found to often be incompatible with other components
of the enzymatic reaction, as well as not being able to achieve a high ’total turnover
number’ (TTN: the total number of moles of product formed per mole of cofactor
over the course of the reaction).45 The lower TTN for electrochemical strategies is
often due to their lack of selectivity when compared with enzymatic regeneration
methods.
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Figure 10 Four most common enzyme catalysis methods of ATP in situ regeneration
At present ATP can only be regenerated via coupled enzyme systems, there are
three different types of kinase enzyme which have been found to be effective in the
regeneration of ATP: acetate kinase, pyruvate kinase and polyphosphate kinase. It
is important to note that while this project focuses on the regeneration of ATP,
due to the promiscuity of both the acetate and pyruvate kinase other NTPs such
as GTP, UTP and CTP have also been regenerated through the use of these kinase
enzymes. Each of the three mentioned kinase enzymes will be discussed in detail in
this section.
1.4.1 ATP Regeneration via Acetate Kinase
Acetate kinase (Figure 10), has been shown by Whitesides to be capable of being
used with two different phosphoryl donors; acetyl phosphate and methoxycarbonyl
phosphate.46 Both of these phosphoryl donor posses their own individual strengths
and weaknesses, which will be detailed below.
1.4.1.1 Phosphoryl Donor: Acetyl Phosphate .
Acetyl phosphate (63) is stable in solution and is a phosphoryl donor of inter-
mediate strength. The ease of synthesis of 63 is main factor that has enabled it
to become one of the most commonly used phosphoryl donors in ATP regeneration
enzyme systems.46 There are two major drawbacks for the use of 63, firstly it has
a hydrolysis half life (25 ◦C, pH 7.5) of 21 h, secondly the acetate ion produced as
a by-product of the ATP regeneration reaction acts as an inhibitor of the acetate
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kinase.47 Inhibition by the acetate ion has been found to only be of real import once
in solutions containing in excess of 1 M acetate, and so 63 has been used successfully
in ATP regeneration systems.46
1.4.1.2 Phosphoryl Donor: Methoxycarbonyl Phosphate .
Methoxycarbonyl phosphate (64) is a high strength phosphoryl donor, and sim-
ilarly to 63 is relatively simple to produce. The by-product of phosphorylation is
methyl carbonate, which undergoes rapid hydrolysis in solution to produce carbon
dioxide and methanol. Immediate decomposition of the methyl carbonate helps to
avoid by-product inhibition, as seen in both acetate kinase with 63 and pyruvate
kinase with phosphoenolpyruvate, as well as diminishing the potential for problems
arising during product isolation.46 The only major drawback of 64 is its half life (25
◦ C, pH 7.5) of 0.3 h, which is inconveniently short.46
1.4.2 ATP Regeneration via Pyruvate Kinase
. Pyruvate kinase can be used as a coupled enzyme in the in situ regeneration
of ATP. Pyruvate kinase utilises phosphoenolpyruvate (65), which is a very strong
phosphoryl donor, unlike the synthesis of both 63 and 64, production of 65 is
complex.
Pyruvate produced as a by-product of the ATP regeneration reaction is an effec-
tive inhibitor of the pyruvate enzyme, thus the reaction must be carried out in dilute
solutions to ensure pyruvate concentration is low, and pyruvate must be removed
upon formation to enable efficient ATP regeneration. The half-life (25 ◦C, pH 7.5)
of 65 is 40 days.
1.4.3 ATP Regeneration via Polyphosphate Kinase
Regenerating ATP from AMP instead of ADP is highly desirable, as many ATP de-
pendant enzymatic reactions produce AMP as opposed to ADP. The use of inorganic
polyphosphates (Poly(P)), (66) to regenerate ATP from AMP is a recent develop-
ment, polyphosphates are linear polymers made up of orthophosphate monomers
linked together by high energy phospho-anhydride bonds.45
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In 2000, Resnick and Zehnder were the first to show that AMP could be used
as an initial reagent, for the production of glucose-6-phosphate with hexokinase.48
Hexokinase produces glucose-6-phosphate from glucose and ATP, producing ADP as
a by-product. Resnick used a polyphosphate:AMP phosphotransferase (PAP) from
Acinetobacter johnsonii to convert AMP to ADP, which was then converted to ATP
by adenylate kinase.48 The ATP produced was then used by hexokinase to produce
glucose-6-phosphate. The substrate specificity of PAP was probed, and it was found
that only AMP showed significant phosphorylation to its relevant nucleoside 5’-
diphosphate, the rate of GMP phosphorylation by PAP was shown to be 4 % of
the rate measured for AMP, while no phosphorylation was found to have occurred
for CMP or UMP.48 While this use of PAP was an innovative leap forward in ATP
regeneration, the method was marred with drawbacks such as a low TTN; and no
cloned gene encoding for PAP.45
Figure 11 a. Resnick system for the production of glucose-6-phosphate using 66 as a
phosphoryl donor for PAP. b. Shiba ATP regeneration, used in the production of
acetyl-CoA, using 66 as the phosphoryl donor for both PAP and PPK reactions
In 2001, Shiba used polyphosphate:AMP phosphotransferase and polyphosphate
kinase (PPK), to show that ATP could be regenerated from AMP using polyphos-
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phate as a phosphoryl donor in both enzymatic reactions (Figure 11 b). 49 This
system was subsequently used in the synthesis of acetyl-CoA from CoA, catalysed
by acetyl-CoA synthase.49 The production of acetyl-CoA required a source of ATP
and generates AMP as a by-product, PAP was used to convert to AMP to ADP us-
ing polyphosphate as a phosphoryl donor, PPK then converted ADP to ATP, again
utilising polyphosphate as a phosphoryl donor.49
The initial concentration of 66 is critical as both PAP and PPK use it as a
phosphoryl donor, as such 66 concentration is the limiting factor in both reactions.
At high concentrations 66 was shown to chelate Mg2+ ions, these divalent metal
ions are essential for enzymatic catalysis, thus resulting in a decrease in the rate
of ATP production. During the synthesis of acetyl-CoA, the amount of acetate
decreased steadily over 16 h, and after 18 h all of the CoA had been converted into
acetyl-CoA.49 Initially only 0.25 mM AMP was added to the reaction, thus over the
course of the 18 h ATP was regenerated 39.8 times, this is significantly higher that
the degree of ATP regeneration in Resnick’s method where ATP was regenerated
between 3 and 4 times.49 Regeneration from GMP was investigated and the dual
enzyme system was found to be capable of regenerating GTP.49
1.4.4 Comparison of ATP Regeneration Systems
. At present, acetate kinase utilising 63 as a phosphoryl donor is the most com-
monly used method of in situ ATP regeneration.50 This subsection will discuss and
compare the advantages and disadvantages of acetate kinase, pyruvate kinase and
the polyphosphate donor systems developed by Resnick and Shiba.49
The pyruvate kinase system is one of the most efficient, due to the use of 65,
which behaves as a strong phosphoryl donor. Pyruvate kinase has a half-saturation
constant (Km ) for ADP of 0.1 mM, while acetate kinase has a Km [MgADP] of 0.4
mM, thus meaning that pyruvate kinase is capable of regenerating ATP at lower
concentrations of ADP46.48 The Km of PAP is 0.26 mM for AMP, while polyphos-
phate kinase has Km = 0.8 µM for ADP, meaning that 66 is tightly bound to the
active site of the kinase and, is used until it decomposes.48
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Scheme 14 Synthetic pathways for the production of (a) 63, (b) 64 and (c) 65.46
A key factor in determining the most industrially useful method of ATP regen-
eration lies in the ease of production of the phosphoryl donor. Figure 14 shows
that synthetic pathways for both 63 and 64 are simple, while 65e has a much more
complex pathway. Unfortunately due to the very short half life of 64 (0.3 h), it
is inconvenient for use in ATP regeneration. Both 63 and 65 have been used suc-
cessfully in ATP regeneration systems, but both come with their own individual
disadvantages, the pyruvate by-product acts as an inhibitor of the pyruvate enzyme
while 63 has a relatively short half life of 21 h. The use of 66 as a donor in ATP
regeneration systems has been shown to be effective, but is not currently widely
used, though 66 is cheap to purchase and could allow phosphorylation from AMP
as opposed to ADP, the strict substrate specificity of polyphosphate kinases means
that only ATP can be effectively regenerated by these kinase enzymes. Our chemo-
enzymatic route towards NTP production, uses inexpensive reagents to produce the
phosphoryl donor and uses a promiscuous NDPK. As such our pathway has the
potential to be used for the regeneration of a range of NTPs.
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2 Protein Production
This chapter describes and discusses the initial production, transformation and ex-
pression of NDPK H122G which was developed by Dr Stefanie Freitag-Pohl, before
moving on to discuss the subsequent purification of the protein. Protein over ex-
pression and purification were originally preformed by Dr Freitag-Pohl during the
first iteration of this project. BL21(DE3) E. coli competent cells were produced
by Dr Freitag-Pohl and frozen, the frozen cells where defrosted by the author then
overexpressed and purified using the methods outlined in Sections 2.2.4 and 2.3.
Firstly, background information relating to the biochemical technologies used
throughout this project will be discussed, after which the methods used to express
and purify the H122G NDPK mutant will be discussed in detail.
2.1 Introduction to Molecular Cloning
The discovery of DNA’s structure by Watson and Crick in the 1950’s, led to an
understanding of the physical basis of genetics 51. Since this fundamental discovery,
advances in genetic engineering have enabled scientists to alter and manipulate the
genetic code, allowing insight into how altering even a single nucleotide can alter
behaviour.
Molecular cloning, the ability to cut, alter and combine DNA molecules together
in vivo, and the use of vector systems to mass produce recombinant DNA, together
form the basis of recombinant DNA technology. This project has utilised both of
these strategies, and so the biochemical background of both will be explored below
in Sections 2.1.1 and 2.1.2.
2.1.1 Isolating DNA fragments
. DNA fragments are primarily amplified via one of two methods, restriction enzymes
or the polymerase chain reaction (PCR). This project only utilised PCR, and as such
restriction enzymes will not be discussed in this report.
2.1.1.1 Polymerase Chain Reaction .
The polymerase chain reaction (PCR), is a process which utilises specific heating
and cooling cycles in the presence of a thermostable DNA dependant DNA poly-
merase to amplify small DNA fragments. There are several essential components in
PCR, firstly a template containing the target sequence, which will be amplified, two
primers (forward and reverse primer) are also present in large excess in the reaction
solution.52 The primers are essential as they specify which fragment of DNA will
be amplified by binding to the template on either side of the fragment. All four
varieties of NTP (A, G, C and T) are present in the reaction solution, as well as
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a thermally stable DNA polymerase, which is responsible for the addition of the
dNTPs onto the forming DNA strands.
There are three stages to the PCR cycle, the first is strand separation; template
DNA is heated to ∼ 95 ◦C causing the two complimentary strands of template
DNA to separate, thus each strand may serve as a template.52 The reaction solution
is then cooled to ∼ 55 ◦C which allows hybridisation of the primers to the DNA
templates, the second stage of PCR. One primer will hybridise to the 3’-end of the
target sequence on one strand, while the second primer will hybridise to the 3’-end
of the complimentary strand, since DNA synthesis occurs in a 5’ to 3’ direction
new NTPs are added to the 3’-end and the two primers are directed towards one
another, thus amplifying the region between the two primers.52 The reaction solution
is heated to ∼ 75 ◦C, and the DNA polymerase elongates both primers across the
target sequence, thus generating two additional copies of the target sequence. These
three stages constitute one PCR cycle, with each cycle the amount of DNA doubles.
Typically between 20-30 cycles are required, after which the main species present in
solution is a DNA fragment whose length is equal to the distance between the two
primers.
2.1.2 Cloning Recombinant DNA
. DNA fragments that have been isolated by PCR or restriction enzymes cannot
immediately be cloned and expressed, instead firstly the DNA fragment of interest
must be up turned into a form which can be replicated by bacterial host cells. As
such the DNA fragment of interest is put into a vector.
2.1.2.1 Vectors .
All vectors have two essential traits, firstly they can be combined with DNA frag-
ments (typically from a different organism than the vector DNA - forming recom-
binant DNA), and they can be capable of replicating autonomously in host cells.52
The most commonly used vectors are plasmids, independently replicating circles of
DNA in bacteria, and bacteriophage, a virus that can inject its genetic information
into bacteria.52
There are three features that all cloning vectors have; (1) an origin of repli-
cation, (2) restriction sites and (3) a selectable marker. Replication of the vector
is initiated by a particular DNA sequence, termed the origin of replication. Two
different restriction enzymes cut both the isolated DNA fragment and the vector,
these restriction enzymes are chosen to give compatible 5’ and 3’-end to the vector
and fragment this ensures not only that the sticky ends of both the vector and the
fragment match, but also that the fragment is inserted into the vector in the cor-
rect orientation.52 DNA ligase then binds the DNA fragment (insert) and the vector
together forming the recombinant DNA, termed a construct. Selectable markers
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allow the detection of host cells containing the construct, and often take the form
of antibiotic resistance. Only cells which contain the vector with antibiotic resis-
tance (also containing the construct) are able to survive when grown on a plate
containing the antibiotic, thus allowing for the easy detection of cells containing the
construct.52 Once the construct has been cloned via a cloning vector, it must then
be put into an expression vector to allow for expression of the protein product. The
construct is then often introduced into competent cells which are permeable to DNA
via transformation. The competent cells (generally bacterial cells) are then grown
in a culture dish, and the colonies of clones containing both the DNA insert and
antibiotic resistance grow.52
2.2 Protein Expression
Expression of the H122G NDPK mutant used four distinct steps, firstly the genetic
insert was generated and amplified from the synthetic gene. In the second step, the
expression vector pOPINF was linearised via double digest. Step three involved the
in-fusion annealing of the linear pOPINF vector and the amplified insert to form a
recombinant plasmid. The plasmid was transformed into BL21(DE3) E. coli cells
for bacterial overexpression in step 4 . Each of these steps will be discussed in detail
in the subsections below.
2.2.1 Step 1: Insert Generation
The synthetic gene (pUC57 cloning vector with ampicillin resistance) for H122G
NDPK was transferred into Stellar competent cells via heat-shock transformation.
The resulting culture was grown over night at 37 ◦C on a liquid broth (LB)/ agar
plate. PCR was then preformed using the temperature cycle in table 1
Table 1 PCR temperature cycle
Step Temperature / ◦C Time / s
1 - Initial Denaturation 98 60
2 - Denaturation 98 10
3 - Annealing 62 15
4 - Elongation 72 30
5 - Final Elongation 72 300
.
Steps 2 - 4 were cycled 30 times before step 5 was completed. After amplification
the products were then resolved on agarose gel (1.5 %), the desired product band was
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cut out and extracted using NucleoSpin gel clean up (Clonetech In-Fusion Cloning
Kit), after which the insert was stored at −20 ◦C.
2.2.2 Step 2: Linearise Expression Vector
Expression vector pOPINF (ampicillin resistant) in the form of a bacterial stab was
grown on LB/ agar plate at 37 ◦C overnight, before undergoing linearisation via
double digest. The double digest used HindIII and KpnI, after linearisation the
product was analysed on an agarose gel (15 %) which is shown in figure 12.
Figure 12 Agarose (15 %) gel of linearised pOPINF
The band containing the digested vector was cut out of the gel and cleaned using
the NucleoSpin kit.
2.2.3 Step 3: Vector-Insert Annealing
A linearised vector to insert ratio of 1 : 3 was used, the plasmid was then transformed
into Stellar competent cells and grown on a LB/ agar plate overnight at 37 ◦C.
Eight colonies from the plate were used to inoculate LB/ ampicillin (50 µL)
mixture, 1 µL of each mixture was then used as a template for PCR following the
temperature cycle in table 1. The amplified products were then resolved on an
agarose gel (15 %), Figure 13. Colonies 2,3,4 and 8 were shown to carry the 500 bp
insert.
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Figure 13 Agarose (15 %) gel of PCR products for eight fusion product colonies
2.2.4 Step 4: Protein Overexpression
After sequencing, to confirm that the insert was present. The plasmid was trans-
formed into BL21(DE3) E. coli competent cells, cultures were then grown in super
optimal broth (SOB) before being transferred to a LB/ ampicillin and chloram-
phenicol plate and grown overnight at 37 ◦C. Colonies from the plate were used to
inoculate LB (1 L).
2.3 Protein Purification
This section will discuss firstly the method via which NDPK H122G was purified,
before moving on to discuss analysis of the purified fractions and subsequent con-
formation that the protein of interest had been purified and isolated.
2.3.1 Purification of NDPK H122G
Cell cultures were grown to an optical density (OD) of 0.7, after which isopropyl
beta-D-1-thiogalactopyranoside (IPTG) (1 M, 1 mL) was added. After further
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growth, the cells were collected and lysed. The supernatant was loaded onto a
1 ml HisTrap column.
The HisTrap column has nickel ions bound to the stationary media, so when cell
lysate flows through the column, proteins containing oligohistidine tags coordinate
to the nickel ions, thus binding the targeted protein to the column. The binding
buffer contains a low concentration of imidazole (30 mM), since imidazole can bind
to nickel ions, it competes with proteins which do not contain a oligohistidine tag,
thus ensuring that all proteins aside from the target protein cannot bind and are
eluted from the HisTrap column. This can be seen during the column wash stage
of the chromatograph (figure 14), the peak which eluted after 6 ml of eluent relates
to these non-desired proteins. The concentration of elution buffer was increased via
a stepwise gradient, from 0, 20, 40, 60, 80 to 100 %. The elution buffer contained
1 M imidazole and so as the % of elution buffer increased so did the imidazole
concentration, at approximately 60% elution buffer a large peak was eluted.
Figure 14 Chromatograph showing the elution of proteins from the HisTrap column.
UV absorbance at 280 nm is shown by the blue line, the conductivity is shown by the
orange line, while elution buffer concentration is represented by the green line.
Analysis of eluent fractions relating to the large peak was done via SDS-PAGE,
to determine if the peak corresponds to the desired NDPK protein. This analysis
will be described in Section 2.3.2.
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2.3.2 Confirmation of NDPK H122G Purification
Samples of all of the fractions relating to the peaks at retention time 37 - 40 minutes
were run, alongside two samples taken from either end of the flow-through to confirm
that NDPK binding was successful in non-eluting conditions.
The molecular weight of NDPK H122G is approximately 19 kDa, as can be seen
from the gel in Figure 15 fractions 2, 3, 4 and 5 correspond to a protein of this
weight, thus we were confident that these fractions contained the desired NDPK
protein. The two flow-through samples show no visible bands at 19 kDa, confirming
that NDPK protein binding to the HisTrap column was successful. The fractions
containing the desired protein were combined and dialysed into HEPES buffer (30
mM, pH 7.5). The dialysed protein was concentrated via centrifugal concentration,
the resulting solution had a volume of 1 ml and a protein concentration of 3.61 mg
ml−1.
Figure 15 SDS-PAGE of fractions collected during purification of NDPK H122G.
Analysed fractions relate to the elution peak shown in Figure 14, M = marker, FT =
flow-through.
2.4 Chapter Summary
This chapter discusses the protein expression and purification of the H122G NDPK
mutant in detail. Protein expression was a four step procedure performed by Dr
Freitag-Pohl; firstly the genetic insert for H122G NDPK was generated and amplified
using Stellar competent cells and a 30 cycle PCR method. After the amplified insert
had been generated and frozen, the expression vector pOPINF was linearised via
double digest using HindIII and KpnI. Annealing of the linearised vector and the
insert required a ratio of 1:3 and resulted in the production of a plasmid, which
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was transformed in to Stellar competent cells and grown overnight on a LB/ agar
plate. Eight of the colonies grown on the plate were subjected to PCR, and of the
amplified products; four of the colonies where shown to carry the H122G NDPK
insert. Colonies containing the insert where transformed into BL21(DE3) E. coli
competent cells. These cells were stored at −20 ◦C.
The frozen BL21(DE3) E. coli competent cells were defrosted by the author. Cul-
tures were grown in SOB before being transferred to and grown on a LB/ampicillin
and chloramphenicol plate. Purification of the cell cultures was done using a HisTrap
column, with a 1 M imidazole elution buffer. The eluted fractions which contained
the desired protein were combined and dialysed into HEPES buffer.
The methods presented in this chapter show how the H122G NDPK mutant
was successfully expressed and purified. After which the mutant was used in the
chemo-enzymatic enzymatic method detailed in Chapter 3, to produce NTPs.
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3 Phosphorylation of Imidazole
3.1 Introduction
This chapter describes the development and subsequent optimisation of a synthetic
route towards phosphoimidazole (62). Firstly, known methods of 62 synthesis will
be discussed, before moving on to the use of direct aqueous phosphorylation, a
method which has been successfully employed by the Hodgson group. 53
3.1.1 Known Methods for the Synthesis of Phosphoimidazole
Phosphoimidazole has a half-life of ∼ 10 days in neutral conditions thus making it
a convenient candidate to serve as a phosphoryl donor. There are currently only
two published methods via which phosphoimidazole has been produced.47,54,55Both
methods require extensive work up due to a range of phosphorylated imidazole
species being produced, thus resulting in arduous and inefficient production of 62.
In 1956, the Rathlev group produced PIm via a three step reaction procedure
(Scheme 15), firstly a phosphoramidate intermediate is formed as the ammonium
salt (73), which is then converted into the potassium salt (74). Imidazole is then
reacted with 74 to form a variety of phosphoimidazole species. The purification of
the reaction products resulted in a relatively low overall yield of the calcium salt of
phosphoimidazole (76) ( ∼ 9 %).55,56
Scheme 15 Reaction scheme for the production of PIm via a phosphoramidate
intermediate56
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In 1961, the Cramer group produced PIm via a two step mechanism which pro-
duced a crude (Et3NH
+)x PO3ImyHz salt (Scheme 16). The values of x, y and z are
determined by the pH of the reaction.
Scheme 16 Cramer reaction scheme for the production of PIm via a crude (Et3NH
+)x
PO3ImyHz salt
3.1.2 Aqueous Phosphorylation Methods
Most organic reactions that require the use of water-sensitive reagents are preformed
under scrupulously dry reaction conditions. However our synthetic route towards
62, utilises the much greater nucleophilicty of amines, when compared to water or
hydroxide, to react phosphoryl chloride (which is highly reactive with water) with
an amine in aqueous solution.
The potential reaction pathways for the formation of 62 are shown in Figure
16. Currently, the exact reaction pathway through which 62 is formed is unknown.
POCl3 can initially undergo either aminolysis to form dichloro-phosphoimidazole
(80) or hydrolysis to form phosphodichloridate (83).
If hydrolysis is the first step 83 is produced as an intermediate species, 83 is an
anionic electrophile and thus can repel attack by hydroxide ions. The greater nucle-
ophilicity of imidazole results in the rate of aminolysis being higher than the rate
of hydrolysis for 83, as such chloro-phosphoimidazole is produced (86). 31P NMR
studies of the crude reaction mixture produced during phosphorylation of imidazole
by POCl3 showed that 1,1’-phosphodiimidazole (82) was produced as a by-product
(2%). This suggests that 86 is unselective and so reacts via a dissociative SN1 like
mechanism. A dissociative mechanism means that the nucleophile which reacts with
86 is controlled by the rate of diffusion, and so is dependant on the concentration
of the nucleophiles in solution, since water has a much higher concentration (∼ 55
M) than imidazole (75 mM) the majority of 86 will undergo hydrolysis to form 62.
The greater rate of aminolysis compared to hydrolysis means that the first step
of the reaction pathway could involve the formation of 80. Chloride ions are good
leaving groups and so the reaction of 80, like that of 86 is likely to be SN1 like
in nature, as such which nucleophile reacts is controlled by the rate of diffusion
and so hydrolysis will be the main reaction pathway due to its higher concentration
producing 86.
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Figure 16 The potential aminolysis and hydrolysis reactions which POCl3 can undergo
during the synthesis of PIm in aqueous media.
3.2 Synthesis of Phosphoimidazole
The method employed to syntheses phosphoimidazole (Scheme 17), in this project
utilised direct phosphorylation of imidazole by reacting 1 equivalent of POCl3 in dry
acetonitrile with imidazole in basic aqueous solution, predissolved. The POCl3 stock
solution was held under argon, to limit hydrolysis before exposure to the reaction
mixture. Six equivalents of sodium hydroxide were used to ensure that the reaction
mixture remained basic throughout the phosphorylation reaction, this was essential
to limit the hydrolysis of the P-N bond in 62.
Scheme 17 The method of phosphoimidazole synthesis utilised in this project
In 1971, Benkovic and Sampson conducted a range of experiments into the hy-
drolysis of phosphoramidate monoanions. The pH-rate profile for the model aliphatic
phosphoramidate, N-(n-butyl)phosphoramidate is shown in Figure 17, the S-shaped
pH-rate graph shown is typical for phosphoramidates in aqueous media.57 It is evi-
dent that as the pH is lowered, the subsequent protonation of the phosphoramidate
results in an increase in the observed rate of hydrolysis. The first rate order constants
for the neutral (k 1) and monoanionic (k 2) phosphoramidate species at 36.8 ∼C are
0.700 × 102 and 0.420 × 102 min−1 respectively, while the second order rate con-
stant associated with hydronium catalysed hydrolysis is 55.5 × 102 M−1 min−1.57,58
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As such to limit scission of the P-N bond via acid hydrolysis, phosphorylation of
imidazole was carried out in basic aqueous media.
Figure 17 Graph showing the log kobds-pH rate profile for the hydrolyis of
N-(n-butyl)phosphoramidate at 55 ◦C. Adapted from57
The 31P NMR spectrum of the crude reaction mixture before purification, con-
tained three signals relating to phosphoimidazole (62), inorganic phosphate (85)
and small levels (2 %) of 1,1’-phosphodiimidazole (82) (Figure 18) . The pres-
ence of inorganic phosphate was confirmed via a ’spike’ experiment where trisodium
phosphate, was added and the inorganic phosphate signal increased significantly. 1H
NMR spectrum of the crude reaction mixture confirmed the presence of unreacted
imidazole.
A purification procedure was adapted from established literature methods by Dr
Freitag-Pohl.47 Initially, acetonitrile was removed via rotary evaporation followed
by freeze drying of the solution, a process which took over 24 h. The crude product
was then subjected to centrifugation in the presence of acetone and sodium iodide,
resulting in the removal of the unreacted imidazole impurity.47
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Figure 18 31P NMR Spectra of PIm crude reaction solution; 85 is at - 4.5 ppm, 62 is a
5.0 ppm and 82 is at 8.2 ppm.
3.3 Optimisation
The following section will firstly describe the experiments that were undertaken to
optimise the initial synthesis of phosphoimidazole, before moving on to discuss the
purification procedures.
3.3.1 Aqueous Phosphorylation of Imidazole
Initially, the reaction of imidazole with POCl3 used 50 mM of imidazole in a 1 to 1
ratio with POCl3, this gave a crude reaction mixture made up of 45% 62, 53% 85
and 2% 82 by 31P NMR spectroscopy. The effect of imidazole concentration upon
phosphorylation was investigated by varying the starting imidazole concentration
between 50 mM and 500 mM, while keeping the molar ratios of imidazole to POCl3
at 1 to 1. The results were analysed via 31P and 1H NMR of the crude reaction
mixtures.
3.3.1.1 Results and Discussion .
Optimal imidazole concentrations were found between 75-250 mM, in this range
conversion to 62 was found to be between 53-55 %. In this range, the rate of
aminolysis was higher than the rate of hydrolysis of POCl3, thus resulting in a
greater levels of 62 being produced. Above 250 mM imidazole, both solubility
and the exothermicity of the reaction became major issues. Despite both 75 mM
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and 250 mM giving 55 % conversion to 62, 75 mM was chosen as the optimum
imidazole concentration, due to the exothermicity of the phosphorylation reaction,
at 250 mM the reaction solution began to reflux spontaneously, thus demanding that
optimisation of reagent concentration be limited to a value of 75 mM imidazole.
Figure 19 Graph showing the % of 62, 85 and 82 produced at a range of initial
imidazole concentrations. (red - 62, blue - 85, green - 82)
3.3.2 Purification Procedure
The initial purification procedure discussed in section 3.2 was extremely time con-
suming, due to the use of freeze drying. As such experiments were conducted into
a purification method which would allow simple production of pure 62 within 24
hours. One of the key goals of optimising the purification protocol was to remove
the use of a freeze-drier from the procedure, as this step was very time inefficient
being in excess of 24 h.
3.3.2.1 Results and Discussion .
It was found that during the initial rotary evaporation step (to remove acetonitrile),
that upon removal of over 80 ml of the 110 ml crude reaction solution (including
the removal of some water), a white solid precipitated out of solution. Analysis of
the precipitate and solvent showed that the supernatant contained mostly 85 and
82, while the precipitate was composed of 81 % 62, 19 85 and 1 % 82 by 31P
NMR. Thus the precipitate was separated from the supernatant via centrifugation
for further purification.
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Table 2 The % of 62, 82 and 85 present in the crude product solution after each of the
purification steps by 31P NMR
% Compound
Purification Step 62 85 82
1st Recrystallisation 85 14 1
2nd Recrystallisation 97 3 0
EtOH Wash 98 2 0
Firstly, the precipitate was recrystallised, initially recrystallisations were pre-
formed in water, however later attempts used 10 mM NaOH, as a basic environment
should limit the rate of hydrolysis of 62 to 85. This change in recrystallisation
solvent resulted in an increase in the proportion of 62, from 79 % to 85 %, after the
first recrystallisation.
After the second recrystallisation the recovered solid contained 97 % 62 and 2
% 85. No 82 was detected after the second recrystallisation.31P NMR was used
throughout to monitor how the % of 62, 85 and 82 changed with each purification
step (Figure 20). 1H NMR revealed that the composition of the recrystallised prod-
uct was 64 % imidazole to 36 % 62, removal of the imidazole impurity is imperative,
as imidazole has been show by Admiraal to be a competitive inhibitor in the H122G
mutant kinase enzyme.43
Initially, after the second recrystallisation, crystals were dried on the high vac-
uum line before being washed with ethyl acetate (50 ml) overnight. A 1H NMR
spectrum of the washed crystals showed that the crystals were composed of 73 %
62 and 27 % imidazole. To allow the removal of more imidazole from the final PIm
compound, after being dried on the high vacuum line the crystals were ground up
with a pestle and mortar before being washed overnight with ethyl acetate (50 ml).
After washing the crystals were again dried, after which they were re-subjected to
1H and 31P NMR, which gave a final product composition of 98 % 62, 2 % 85 by
31P NMR spectrum and 79 % 62 and 21 % imidazole by 1H NMR spectrum, as such
the purification procedure needs to be further optimised, potential ways to improve
purification will be discussed in Section 5.2.1.
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Figure 20 31P NMR Specta of PIm (a) crude reaction solution, (b) crystals formed
after the first recrystallisation, (c) crystals formed after the second recrystallisation
3.4 Conclusions
Optimisation of both the synthetic route and the purification procedure of phospho-
imidazole, has allowed for the production and partial purification of 62 using easy
and time efficient methods. Investigations into the optimum concentration for the
synthetic pathway allowed for improved conversion to 62.
Optimisation of the purification procedure, resulted in the reduction of P-N
bond scission, via the use of a basic aqueous solvent for recrystallisation. The
use of a pestle and mortar to grind up the crystals, produced after the second
recrystallisation (thus increasing surface area), resulted in a large decrease in the
amount imidazole found in the final compound which is essential for the effective
use of 62 with the H122G kinase enzyme.
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4 Enzyme Assays and Analysis
This chapter describes firstly, the various high performance liquid chromatography
(HPLC) columns and methods used over the course of this project. HPLC was used
to monitor the kinetics of the phosphorylation of NDPs by the PIm/ NDPK H122G
system. The various enzymatic experiments, investigating the effect of impurities
and PIm concentration on the total % conversion of ADP to ATP will be detailed.
4.1 HPLC Analysis
The kinetics of NDP phosphorylation reactions preformed over the course of this
project were monitored via HPLC. Reactions were monitored using two reverse
phase analytical HPLC columns; SUPELCOSIL-LC-18-T and SIELC-Primesep SB
columns were used to analyse the conversion of ADP/ATP and GDP/GTP respec-
tively.
4.1.1 HPLC Columns
The development of HPLC methods has allowed for the separation and resolution
of a plethora of biological molecules.59 Molecules such as proteins, peptides and
nucleotides which posses a degree of hydrophobic character, are predominantly sep-
arated via reversed phase chromatography.60
Two types of reverse phase column were used in this project, a reverse-phase
column that is able to run 100 % aqueous elutent (SUPELCOSIL-LC-18-T) and a
mixed mode reverse-phase column (SIELC-Primesep SB) that also possesses anionic
exchange characteristics. Both of these columns use octadecylsilane (C-18) bonded
stationary phase, which allows retention and separation of the nucleotides being
analysed.
Analysis of both the ATP/ADP and GTP/GDP systems was investigated with
the SUPELCOSIL-LC-18-T column, and it was found that while the nucleotides of
the ATP/ADP system had significant retention times and were well separated, the
GTP/GDP system eluted at the solvent front. On this basis the SIELC-Primesep
SB column was used for the analysis of the GTP/GDP system, as the column was
able to retain the nucleotides, allowing for the production of significant retention
times and well separated nucleotide peaks.
4.1.1.1 Reverse-Phase Column .
Separation of nucleotides by reversed-phase HPLC depends on the strength of the
hydrophobic binding interaction between the nucleotides and the immobilised hy-
drophobic C-18 stationary phase.59
Gradient elution systems, which proceed from an initial aqueous buffer to a
buffer containing organic solvent, are commonly used for the separation of biologi-
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cal molecules. In the initial aqueous mobile phase, there is a high degree of organised
water structure around the hydrophobic C-18 ligands and the nucleotides.61 Reduc-
tion of the exposure of these hydrophobic elements to the aqueous mobile phase
is entropically favourable, and as such nucleotides and the C-18 ligands bind to-
gether.61 The more phosphate groups that are attached to a nucleotide, the less
hydrophobic the nucleotide is and so the shorter its retention time on a reversed
phase column. Over the course of the HPLC elution gradient the proportion of
organic solvent in the mobile phase is increased. This causes a reduction in the
polarity of the mobile phase, allowing for the de-absorption of nucleotides from the
C-18 stationary phase.61,62
Nucleotide polarity determines the order in which nucleotides are eluted from
the column, NTPs are the most polar, have the shortest (often negligible) retention
times and, are eluted first followed by NDPs and NMPs.
4.1.1.2 Reverse-Phase Columns with Ionic Properties .
Reverse-phase HPLC is typically performed at low pH, non-polar molecules are
retained effecively by the column.63 Acidic molecules, which remain ionised at low
pH do not tend to be retained by the column, as such ion pairing reagents are
traditionally used to increase retention time.
4.1.1.2.1 Ion Pairing Reagents .
Ion pairing reagents have a hydrophilic head and a long hydrocarbon hydropho-
bic tails, they are added to the mobile phase to increase retention time of charged
analytes.63 The hydrophobic tails interacts with the hydrophobic C-18 stationary
phase of the column, thus leaving the charged hydrophobic head exposed in the mo-
bile phase, where it can interact with oppositely charged solute molecules.63 These
electrostatic interactions result in an increase in retention time. Since nucleotides
are anionic, they require the use of cationic ion paring reagents such as tetra-n-
butylammonium hydrogen sulfate (CH3CH2CH2CH2)4N(HSO4).
The use of ion pairing reagents, is not without its drawbacks. Firstly, the use of
an elution gradient is difficult due to the need for a long column equilibration time
between analytical experiments.64 This time is required to ensure the redistribution
of the ion pairing reagent after the use of a gradient elution system, and can often
be longer than the time required for the elution gradient experiment.63 After the
column has been exposed to an ion pairing reagent, due to the strong hydrophobic
interactions between the hydrocarbons chains of the stationary phase and the tail of
the ion paring reagent, even after extensive washing of the column the ion pairing
reagent cannot be completely removed.63
4.1.1.2.2 Mixed Mode Column .
The use of mixed mode columns in place of ion exchange reagents has become more
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prevalent in recent years, as they are able to provide both ionic and reverse-phase
characteristics63.65
Mixed mode columns, unlike traditional reverse-phase and ion exchange columns,
allow solutes to interact with the stationary phase of the column via more than one
mechanism. They are capable of retaining either basic or acidic compounds, depend-
ing on the ionic group used, which cannot be retained by reverse-phase columns.
The main interaction mechanism between the solute and the stationary phase is
determined by both the elution conditions and the properties of the solute molecule.
Mixed mode columns which display reverse phase and ion exchange character-
istics (e.g. SIELC-Primesep SB) can be categorised into four types of stationary
phase (Figure 21). Type 1 stationary phases are achieved by mixing particulates
of separation media with different chemical properties together, then packing the
column with the mixture. Type 2 stationary phases utilises ligands with different
functionalities.
Most commercial mixed mode columns are either type 3 or 4, the Primesep SB
column used in this project is type 3. The difference between type 3 and 4 lies in
the positioning of the ionizable functional group, if the group is positioned close
to the surface of the silica gel, and the C-18 tail extends into the mobile phase
the functional group is embedded (type 3), if the functional group is positioned at
the end of the hydrocarbon chain (tipped) then the stationary phase is type 4.66
Hydrogen-bond acceptors such as amide, urea and carbamate are some of the most
widely used polar groups used in type 3, reverse phase/ion exchange mixed mode
columns.
Figure 21 Four types of bimodal column media that can be used in mixed mode
reverse-phase/ion exchange columns, blue - ion exchange, black - reverse-phase. Adapted
from66
4.1.2 Enzymatic Assay Analysis
The conversion of NDP to NTP via H122G NDPK was monitored using analytical
HPLC. HPLC of the adenosine system has been performed on a SUPELCOSIL LC-
18-T column (250 × 4.6 mm) with a Supelguard LC-18-T guard column, while the
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guanine system was analysed using a SIEL-Primesep SB column (150 × 4.6 mm),
full column details in sections 6.5.2 and 6.5.3.
4.1.2.1 Conversion to ATP .
Kinetics of NDPK H122G catalysed phosphorylation of ADP to ATP was monitored
on a SUPELCOSIL LC-18-T column, using UV detection at 254 nm. The initial
elution system, used a liner gradient of 0 - 25 % methanol in ammonium acetate
(0.05 M, pH 5.9) over the course of 15 minutes.67 Chromatographs produced for
the analysis of adenosine nucleotides using this elution system, displayed poor peak
separation and a high degree of peak tailing. Improvement of the methanol/ ammo-
nium acetate elution system was attempted, firstly to prevent ATP from eluting at
the solvent front a stepped gradient elution system was used - this resulted in longer
retention times but had no improvement on peak separation and tailing. The effect
of changing the pH was investigated using a range from pH 5.5 - 7, no improvement
in peak separation or tailing was observed. As such a different literature protocol
was investigated, a gradient elution system used again.68 The new mobile phase used
two phosphate buffers (6.5.1), buffer A = KH2PO4 (0.1 M, pH = 6.0) and buffer B
= A : methanol (90:10). Analysis of ATP and ADP via this method resulted in well
defined peaks, with clear separation as shown in figure 22
Figure 22 Chromatograph showing the separation of ATP, ADP and AMP over the
course of an analytical chromatographic experiment using SUPELCOSIL LC-18-T.
4.1.2.2 Conversion to GTP .
Chromatographic experiments monitoring phosphorylation kinetics of GDP to GTP,
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were done on mixed mode Primesep SB column using UV detection at 254 nm by
Dr Stefanie Freitag-Pohl.
A linear gradient elution system was used to elute the nucleotides over 30 min-
utes, using two ammonium acetate based buffers. Buffer C = ammonium acetate,
(30 mM, pH 4.5) 5 % ACN and buffer D = ammonium acetate (200 mM, pH 4.5), 5
% ACN, the linear gradient went from 70 % C, 30 % D to 100 % D over 30 minutes.
Analysis of GTP and GDP via this method resulted in well defined peaks, with clear
separation as shown in Figure 23.
Figure 23 Chromatograph showing the separation of GTP and GDP over the course of
an analytical chromatographic experiment using column Primesep SB.
4.2 Enzyme Assays
The key goal of the enzymatic experiments carried out, was firstly to determine
whether PIm was capable of rescuing the activity of the H122G mutant kinase, then
to investigate the parameters that affect conversion of NDP to NTP.
Figure 24 Production of an NTP via the rescue of H122G NDPK mutant activity by
the use of phosphoimidazole as a phosphoryl donor.
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4.2.1 Pilot Experiment: Dephosphorylation of ATP
Rescue of the activity of the H122G NDPK mutant by imidazole was first demon-
strated by the Herschlag group in the late 1990’s (scheme 6), the first enzymatic
assay undertaken was to repeat this experiment69. This was done to ensure that
imidazole was able to rescue activity of the NDPK H122G, produced during this
project. The principle of microscopic reversibility, means that the reverse reaction
using PIm and ADP to produce ATP and imidazole would be possible.
4.2.1.1 Results and Discussion .
Three reactions were performed in parallel. Reaction I was a positive control exper-
iment and contained ATP, NDPK H122G and imidazole, reactions II and III were
both negative control experiments containing ATP and NDPK H122G or ATP and
imidazole, respectively.
Pleasingly, dephosphorylation of ATP only occured during reaction I when all
three reactants were present, removal of either the imidazole or the enzyme com-
ponent resulted in no dephosphorylation reaction occuring, thus no conversion to
ADP. Samples from the three parallel reactions were taken at 0, 15, 60 and 90 min-
utes during the pilot experiment, 15 minutes was chosen over 30 minutes as the rate
of dephosphorylation was expected to be higher at the start of the reaction. The
samples were analysed via HPLC. Figure 25 clearly shows an increase in the % of
ADP in reaction I from 0.2 % upon initiation of the reaction to ∼ 16 % after 90
minutes.
Figure 25 Graph showing dephosphorylation of ATP in positive control experiment I to
produce ADP during the initial pilot experiment
4 ENZYME ASSAYS AND ANALYSIS 46
4.2.2 Initial Enzymatic Phosphorylation Reaction of ADP to ATP
Firstly, the capability of phosphoimidazole to rescue activity of the H122G NDPK
mutant had determined. This was done by a performing three reactions in parallel.
The compositions of the three reactions are shown in Table 3.
Table 3 Composition of the initial parallel enzymatic experiments
Reactant
Experiment PIm H122G
NDPK
IV + +
V - +
VI + -
4.2.2.1 Results and Discussion .
The three parallel experiments were all completed under the same reaction condi-
tions, both IV and VI used PIm from the same crude stock solution, all three of
the reactions were performed at room temperature in HEPES buffer at pH 7.5.
Figure 26 Graph showing the % conversion to ATP in the initial 3 parallel reactions:
IV (×), V (+) and VI (×) over the course of a 2 h enzyme catalysed phosphorylation
reaction.
Aliquots of all three reaction solutions were taken at time points of; 10, 60, 90
and 120 minutes. The samples were then subjected to centrifugation through a 10
000 kDa molecular weight cut off filter. Which allowed easy and efficient removal of
the enzyme from the samples. The samples were then analysed via HPLC, the graph
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shown in Figure 26 shows that only IV resulted in conversion from ADP to ATP
in a time-dependant manner. Both V and VI displayed no conversion from ADP
to ATP over the course of 2 hours, thus showing that under the reaction conditions
used, the H122G enzyme is incapable of catalysing the phosphorylation of ADP to
ATP.
4.2.3 Effect of Impurities and [PIm] on % Conversion
The enzymatic reactions were carried out under a variety of conditions, to ascertain
the effect that both impurities, such as imidazole and acetonitrile, and the initial
PIm concentration had on the total conversion of ADP to ATP.
Herschlag showed that at high concentrations imidazole is capable of acting as
an inhibitor of NDPK H122G, as such particular emphasis was placed on the study
of how the presence of excess imidazole effected the total conversion of ADP to
ATP.43 The effect of acetonitrile on ADP phosphorylation was also investigated, to
determine if the removal of acetonitrile from crude PIm solutions was imperative.
4.2.3.1 Effect of impurities on % conversion to ATP .
The initial crude PIm reaction solution contained acetonitrile and 50 % imidazole
by 1H NMR, to determine if the crude reaction mixture could be used without
further purification the effect of these two impurities on total ATP conversion was
investigated.
4.2.3.1.1 Results and Discussion .
To determine the effect that acetonitrile and imidazole impurities had on the total
% conversion of ADP to ATP via H122G NDPK mediated phosphorylation three
enzymatic assays were carried out. All of the reactions used the same batch of freshly
made crude PIm reaction solution which had been adjusted to pH 7.5; reaction VII
had deionised water added to the crude PIm, while reaction VIII had acetonitrile
added to the crude PIm and reaction IX had 30 mM imidazole added to the crude
PIm (Table 4).
Table 4 Composition of the impurities parallel enzymatic experiments
Added Impurities
Experiment H2O ACN IM
VII + - -
VIII - + -
IX - - +
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Samples from the three reactions were taken at various time points of; 10, 30, 60
90 and 120 minutes and analysed via HPLC. Analysis of the three reactions showed
that IX yielded the largest reduction in conversion after 2 h, this was expected as
the Herschlag group has previously shown that for the reverse reaction imidazole
acts as an inhibitor at high concentrations.43
Figure 27 Graph showing the total % conversion to ATP for VII (×), VIII (+) and
IX (∗) after 2 hours
The % conversion from ADP to ATP for the three reactions over 2 h is shown in
Figure 27. Reaction VII showed a total conversion of 37 %, reaction VIII was 20
% and reaction IX was 15 %. The drop in total % conversion of ADP to ATP was
17 % and 22 % for reactions VIII and IX, respectively when compared to reaction
VII. The large reduction in total % conversion to ATP showed that, to maximise
enzymatic conversion it is imperative that both imidazole and acetonitrile impurities
are minimised as much as possible if not completely removed.
4.2.3.2 Effect of [PIm] on % conversion to ATP .
The effect of PIm concentration on the total % conversion of ADP to ATP was
investigated between 5 - 50 mM PIm, the results were analysed via HPLC (Section
6.5.2).
It should be noted that during the investigation into the effect of initial phospho-
imidazole concentration on % conversion to ATP, the reactions were only performed
once due to the H122G NDPK enzyme denaturing. This resulted in the investiga-
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tion being halted while a new batch of the enzyme was produced, due to the time
constraints of the project the investigation was not completed and so a through
assessment of the errors associated with the results presented in this section could
not be conducted.
4.2.3.2.1 Results and Discussion .
It was found that as the concentration of PIm was increased, both the total %
conversion to ATP and the initial rate of ATP formation increased.
Figure 28 Graph showing the % conversion to ATP after 24 hours for reactions with an
initial PIm concentration of 5 mM (1), 10 mM (2), 20 mM (3) and 50 mM (4)
The % conversion after 24 hours were; 12 %, 14 %, 30 % and 43 % for the 5, 10,
20 and 50 mM reactions respectively. Figure 29 shows how the % conversion from
ADP to ATP progressed for each of the PIm concentrations over the course of 5 h.
The 50 mM PIm reaction produces not only the highest % conversion to ATP after
5 h, but also has the steepest initial gradient implying that it has the greatest initial
rate of reaction.
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Figure 29 Graph showing the % conversion of ADP (61) to ATP (16) after 5 h for 5
mM (4), 10 mM (), 20 mM (+) and 50 mM (×) phosphoimidazole
Due to the nature of the enzymatic system and the absence of a fully delineated
model, analysis of the kinetics of the formation of ATP was not simple. Due to
the complexity of the reaction, the initial gradient from the kinetic results and
the % conversion between 10 - 30 minutes were used to give an estimate of the
quantitative effect that PIm concentration had on the rate of the enzyme mediated
phosphorylation reaction.
Figure 30 Graph showing how the initial rate of ATP formation changed for various
PIm concentrations, 5 mM (1), 10 mM (2), 20 mM (3) and 50 mM (4)
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Figure 30 clearly shows a positive relationship between the concentration of PIm
and the initial rate of phosphorylation of ADP. The initial rate of the phosphoryla-
tion reactions of PIm concentrations: 5 mM, 10 mM, 20 mM and 50 mM are 0.752
× 10 8, 1.263 × 10 8, 1.627 × 10 8 and 2.588 × 10 8 M s−1 respectively.
Analysis of both Figure 28 and Figure 30 allowed for the conclusion that both
initial velocity and degree of conversion to ATP are positively correlated with PIm
concentration.
4.2.4 Enzymatic Phosphorylation of GDP
Enzymatic studies into the phosphorylation of GDP to form GTP were undertaken
during the first iteration of this project by Dr. Stefanie Freitag-Pohl at the Univer-
sity of Durham.
Scheme 18 Formation of GTP via H122G NDPK enzyme catalysed phosphorylation of
GDP
These experiments established whether H122G NDPK was compatible with guano-
sine based nucleotides and thus whether it could be used to generate GTP. Two
reactions were run in parallel: reaction X were both PIm and the NDPK H122G
enzyme were present in the reaction solution, and reaction XI were only PIm was
present in the reaction mixture. The composition of the two reactions is shown in
Table 5.
Table 5 Composition of the GDP parallel enzymatic experiments
Reactant
Experiment PIm H122G
NDPK
X + +
XI + -
4.2.4.1 Results and Discussion .
The two parallel experiments were completed under the same conditions, using PIm
from the same purified batch which had the pH adjusted to 7.5. The reactions were
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Figure 31 Graph showing % composition of 1 over the course of 47 hours; % GTP
(+),% GDP (×)
preformed at room temperature and samples were taken and analysed every hour
for the first 5 hours, then at 23 h and the final sample was taken at 47 h.
Over the course of the 47 hours, reaction XI showed no change in the levels
of GDP or GTP, both remained at 100 % and 0 % respectively. Figure 31 clearly
shows that this was not the case for reaction X, the % of GTP steadily increased
from 2 % at 10 minutes up to 55 % after 47 hours. As time progresses the rate
of phosphorylation of GDP decreases and, between 23 to 47 hours the equilibrium
position seems to be further to the right than it was between 10 minutes and 5
hours, as the % of GTP only increased by 5% over a 24 hour time period where as
in the first 5 hours, % GTP increased by 20%.
4.2.5 Bioluminescence Studies
Research into the ability of the H122G enzyme to produce ATP in the presence
of a biochemical system that consumes ATP, was undertaken by Dr Hodgson. As
discussed in Section 1.4, biocatalysis for cofactor regeneration has become more
prevalent in recent years, and the potential capability of the PIm/ NDPK H122G
for ATP regeneration in the presence of an ATP cofactor dependant enzymatic
system was explored.50
Scheme 19 ATP-dependant bioluminescence reaction, catalysed by firefly luciferase.
The ATP test kit was chosen, due to the sensitivity and simplicity of the luciferase
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reaction (Scheme 19), which uses the luciferase enzyme to catalyse the reaction of D-
luciferin (88) to oxy-luciferin (89). The test kit is capable of detecting the presence
of ATP at low concentrations (10−12 M).
To test the compatibility of the H122G mutant with the luciferase enzyme, in-
stead of adding ATP to the luciferase enzyme, H122G NDPK, PIm and ADP were
added.
Scheme 20 Phosphorylation of ADP by NDPK H122G to form ATP, an essential
co-factor the luciferase catalysed reaction.
A series of reactions were carried out by Dr Hodgson, each of the reactions used a
stock reaction solution (Section 6.4.2) crude PIm and NDPK H122G (0.2 mg ml−1)
stock solution.
An initial pilot reaction (XII), and reaction to asses the effect of increased PIm
concentration XIII were undertaken by Dr Hodgson. Each of the reactions used
a stock reaction solution (Section 6.4.2)of crude PIm and NDPK H122G (0.2 mg
ml−1) stock solution
Both of the reactions consisted of five experiments which were ran in parallel,
the components present in each of the five experiments are given in Table 6.
Table 6 Composition of the five bioluminescent assays
Experiment
Component a b c d e
ADP - + + + -
PIm - + + - +
H122G - + - + +
4.2.5.1 Reaction XII: Positive Control Experiment .
Initially, a positive control experiment was carried out to confirm that in the absence
of ADP (100 mM), NDPK H122G or PIm, the luciferase catalysed reaction did not
give a luminescent signal above background level.
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4.2.5.1.1 Results and Discussion .
The reaction solution (100 µL) was pipetted into wells of a black bodied microtiter
plate, and 1 µL of ADP, PIm and NDPK H122G was added depending on the
experiment being preformed.
Figure 32 Luminescence signals of the 5 experiments performed during reaction XII.
Reaction a (×), b (+ ), c (∗), d (•), e (4)
The largest luminescent signal was seen in experiment XIIb, which contained
ADP, PIm and NDPK H122G. The background luminescent signals for XIIc and
XIId are significantly larger than those seen in XIIa and XIIe, this is most likely
due to ATP contamination of the ADP stock solution. Commercial nucleotides such
as ADP are generally extracted from whole organisms, and as such are prone to low
levels of contamination by other nucleotides.
4.2.5.2 Reaction XIII: Increased PIm Concentration .
The effect of PIm concentration on the rate of ATP generation was also explored.
The 5 parallel experiments were conducted using using a higher concentration of
PIm and NDPK H122G.
4.2.5.2.1 Results and Discussion .
The reaction solution (100 µL) was pipetted into wells of a black bodied microtiter
plate, where necessary water (18 Ω ) was added to maintain reagent concentration
across all 5 parallel experiments
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Figure 33 Luminescence signals of the 5 experiments performed during reaction XIII.
Reaction a (×), b (+ ), c (∗), d (•), e (4)
Over the course of the reaction, a significant increase in the luminescent signal
from reaction XIIIb can clearly been seen in figure. This increase is indicative
of a build up of ATP, produced via the enzymatic phosphorylation of ADP by
NDPK H122G. The background luminescence signals, for XIIc and XIId relating
to contamination of ATP, remained constant over the course of the reaction.
4.2.5.3 Analysis of Bioluminescent Reactions at Later Time Points .
Luminescent signals resulting from contamination of the ADP stock solution by ATP,
such as experiments XIIIc and XIIId were expected to decrease as reaction time
increased owing to the consumption of the ATP contaminant. While the luminescent
signal produced by the positive control was expected to either increase or remain
steady, as NDPK H122G catalysed the production of more ATP.
4.2.5.3.1 Results and Discussion .
Reaction XIII was re-analysed 0.25 h after initiation of the reaction, Figure 34
shows a decrease in the luminescent signals for negative control reactions XIIIc
and XIIId, indicating that the ATP contaminant in both of XIIIc and XIIId is
being used up. Luminescent signals for XIIIb, are higher than those observed in
the original analysis, this is due to the increased concentration of ATP, produced
by the NDPK H122G enzymatic phosphorylation reaction.
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Figure 34 Luminescence signals of the 5 experiments performed during reaction XIII
0.25 h after initiation. Reaction a (×), b (+), c (∗), d (•), e (4)
The longevity of the reactions was investigated. The reactions were stored at
4 ◦C overnight, and then allowed to equilibrate to room temperature before being
analysed at a single time point (Table 7).
Table 7 Luminescence signals for all 4 reactions after being kept at 4 ◦C overnight
Luminescence Signal
Reaction a b c d e
XII 8 6173 90 336 4
XIII 4 1787 5 14 5
Experiments XIIc and XIId, both show a significant reduction in luminescence
signal, with signal intensities ∼ 3 % and ∼ 11 % of those recorded 10 minutes after
reaction initiation, while the luminescent signal for XIIb has only decreased 2-fold.
Reaction XII shows large luminescent signals for the positive control reaction XIIb,
and low background luminescent signals for the negative control reactions. Experi-
ment XIIb, shows a large signal, which is ∼ 70 % of that recorded 10 minutes after
reaction initiation, and ∼ 39 % of the signal recorded 0.25 h after initiation. Lumi-
nescent signal recorded for XIIb is also ∼ 250-fold above background luminescence.
Analysis of the results of the two reactions, shows that only the positive con-
trol reactions (XIIb and XIIIb) displayed luminescence signals significantly above
background luminescent levels, after overnight storage. The luminescence signal due
to ATP contamination had significantly reduced after overnight storage, to the level
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of background luminescence. The increase in the luminescence signal of XIIIb was
due to ATP produced in situ by the NDPK H122G catalysed phosphorylation reac-
tion. These results confirm that the NDPK H122G system is compatible with the
luciferase system, and can be used as an ATP generation system.
Figure 35 Luminescence signals of the 5 experiments performed during reaction XIII
after overnight storage
4.3 Conclusions
Firstly, the development of HPLC protocols for both the SUPELCOSIL-LC-18-T
and Primesep SB columns allowed for the clear separation and resolution of their
respective nucleotide series, thus allowing for the kinetics of NDPK H122G catalysed
phosphorylation reactions to be monitored.
Initial experiments confirmed that the H122G mutant was capable of using PIm
to rescue enzyme activity, the use of negative control experiments showed that with-
out PIm present phosphorylation of the NDP did not occur. The effect of imidazole
and acetonitrile on the total % conversion of the enzymatic reaction was investi-
gated, the presence of imidazole and acetonitrile in the reaction mixture was shown
to be detrimental to % conversion. As such, optimisation of the PIm purification
procedure was done, to minimise the amount of these impurities present in the
reaction solution (Section 3.3.2 ).
The effect of % conversion to ATP was investigated between 5-50 mM PIm, these
experiments clearly showed a positive relationship between concentration of PIm
and the total % conversion to ATP after 24 h. Initial rate of phosphorylation was
calculated, to give an indication of how PIm concentration effected the initial rate, it
was found that as PIm concentration increased so did initial rate of phosphorylation
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with PIm concentrations 5, 10, 20 and 50 mM showing initial rates of 0.752 × 10 8,
1.263 × 10 8, 1.627 × 10 8 and 2.588 × 10 8 M s−1 respectively.
Biocatalysis for the regeneration of cofactors, such as ATP in situ with other
ATP dependant enzymatic reactions has gained traction in both academia and in-
dustry in recent years.44 As such the PIm/NDPK H122G system was used in the
presence of the luciferase catalysed reaction of D-luciferin to oxy-luciferin, which
produces a luminescent signal which was monitored for the initial 10 minutes after
reaction initiation and after overnight storage at 4 ◦C. Negative controls were used
in each iteration of these experiments, which allowed for the identification of ATP
contamination present in the ADP stock solution. After overnight storage, only
the positive control reactions remained significantly above background levels, thus
showing the ATP contaminant had been consumed and the luciferase reaction in
the positive control experiment was using ATP produced in situ by the PIm/NDPK
H122G system.
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5 Conclusions and Future Work
This chapter will firstly discuss the salient points and conclusions of this project,
before considering the available scope for further work. Particular emphasis will
be placed on the preliminary work done on the synthesis of thio-phosphoimidazole
(PSIm) performed by the author and Dr Freitag-Pohl.
5.1 Conclusions
5.1.1 Optimised Synthesis of Phosphoimidazole
The synthesis of phosphoimidazole (62, Scheme 17) from cheap, readily available
reagents is detailed in Chapter 3. The method for the production of 62, a phosphoryl
donor, was streamlined and optimised which resulted in the production of high
purity 62. The optimisation process examined the optimum initial imidazole (75)
concentration and the steps used in the purification procedure of crude 62.
Investigation into the initial concentration of 75 resulted in an increase in the
% of 62 present in the crude reaction solution. The original reaction used 50 mM
75 in a 1 to 1 reaction ratio with POCl3 (72), which resulted in a crude reaction
solution of 62, inorganic phosphate (85) and 1,1’-phosphodiimidazole (82) with a
composition of 45, 53 and 2%, respectively. The % of 62 found in the crude reaction
solution was 55%, when the concentration of 75 was increased to 75 mM (Table 8).
Table 8 The % of 62, 82 and 85 present in the crude product solutions produced by
reactions with different initial concentrations of imidazole (31P NMR)
% Compound
[75] /mM 62 85 82
50 45 53 2
75 55 43 2
The original purification procedure involved freeze drying the reaction solution, a
process which took 24 h. The crude product was then dissolved in acetone containing
sodium iodide, to facilitate the removal of the imidazole impurity. Phosphoimidazole
is a time-sensitive compound and as such the main goal of purification optimisation
was to remove the use of a freeze-drier.
Rotary evaporation of the crude reaction solution lead to the formation of a white
precipitate, upon analysis via 31P NMR the precipitate was found to consist of 81%
62, 19% 85 and 1% 82. The precipitate was then recrystallised twice in 10 mM
sodium hydroxide, after the second recrystallisation the recovered solid contained
97% 62 and 3% 85. The precipitate was then ground up and washed overnight using
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EtOH, after drying the final product consisted of 98% 62 and 2% 85 by 31P NMR.
Analysis of the final product via 1H NMR gave a product composition of 79% 62
and 21% 75.
5.1.2 Use of Phosphoimidazole in Biocatalytic Reactions
The principal goal of the enzymatic experiments was to determine whether 62 was
capable of behaving as a phosphoryl donor, and thus capable of rescuing the activity
of the mutant H122G NDPK enzyme (Chapter 4). The initial phosphorylation reac-
tion (Section 4.2.2) of ADP was conducted using a crude reaction solution containing
45% 62, after 2 h the % conversion from ADP to ATP was 25%.
The effect of impurities and initial 62 concentration was investigated (Section
4.2.3). Three reactions were ran in parallel to determine the effect that acetonitrile
and imidazole impurities had on the % conversion from ADP to ATP. After 2 h,
the % conversion to ATP was 37%, 20% and 15% for the reactions containing no
added impurities, added acetonitrile and imidazole, respectively. The significant
drop in the % conversion to ATP when acetonitrile or imidazole impurities were
present, gave a clear indication that the removal of these impurities was essential to
maximise enzymatic conversion from ADP to ATP. The effect of the concentration
of 62 on % conversion to ATP was investigated, after 24 h the % conversion to ATP
for the reactions with initial 62 concentrations of 5, 10, 20 and 50 mM was 12, 14,
30 and 43%, respectively.
The promiscuity of the H122G NDPK enzyme was demonstrated by the produc-
tion of ATP by the author and GTP by Dr Freitag-Pohl, both reactions used 62 to
rescue the activity of the mutant enzyme.
Biocatalysis for the in situ generation of cofactors such as ATP, has become
more popular in recent years. The potential of the 62/ H122G NDPK system to
be used as a ATP generation system in the presence of an ATP cofactor dependant
enzymatic system was investigated by Dr Hodgson. The results of these experiments
clearly showed that the 62/ H122G NDPK system was capable of producing ATP
in the presence of the luciferase enzyme, which in turn used the ATP to produced a
bioluminescent signal.
5.2 Future Work
5.2.1 Further Optimisation of the Production of PIm
Further optimisation of the conditions of both the synthetic reaction and the purifi-
cation procedure, would increase the efficiency of PIm synthesis by increasing both
the overall yield and the purity of the final PIm product.
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5.2.1.1 Optimisation of the Reaction Conditions of PIm Synthesis .
Optimal imidazole concentrations were found between 75 - 250 mM (Section 3.3.1),
the highest conversions were achieved by 75 mM and 250 mM with a total conversion
to PIm for 55 %. Due to the exothermic nature of the reaction, 75 mM imidazole
was chosen as the optimum imidazole concentration. In a future iteration of this
project the effect of preforming the phosphorylation of imidazole reaction on ice
should be investigated, as this may allow the use of higher initial % of imidazole to
be used, which allow for a greater mass of PIm to be produced.
5.2.1.2 Optimisation of PIm Purification Procedures .
The purification procedure of PIm described in Sections 3.2 and 6.3.1, achieved a
partially pure product. 31P NMR spectra gave a final product composition of 98 %
PIm, 2 % Pi, while
1H NMR spectra gave a final composition of 79 % PIm and 21
% imidazole. Since imidazole has been shown to behave as an inhibitor of NDPK
H122G, the removal of the imidazole impurity is imperative to achieve the highest
% conversion from NDP to NTP using the mutant enzyme.43
Further optimisation of the purification procedure could be done by investigating
the effect of washing the final compound with acetone and sodium iodine, this
method was used by Crammer in 1961 to remove the imidazole impurity after the
production of PIm.47
5.2.2 Thiophosphorylation of Imidazole
Scheme 21 The method of γ-thio-phosphoimidazole synthesis utilised in this project
The use of γ-thio-nucleoside 5’-triphosphates (NTPγS), is a well established method
of investigating the mechanistic pathways of nucleotides.70 In more recent years,
NTPγSs have been used to clarify the roles of a variety of protein kinases, via
identification of substrates and elucidation of the effect that phosphorylation has on
substrate function.71 ATPγS has found particular use in investigative roles involving
the function of protein kinases. ATPγS behaves as a phosphate donor, producing
thiophosphorylated proteins which unlike there phosphorylated analogues are resis-
tant to protein phosphatases.71 The inclusion of the unnatural P-S bond into the
phosphorylated product, allows for the modification and subsequent detection of the
thiophosphorylated product.
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Preliminary investigations into synthesis of PSIm (Scheme 21), have been pre-
formed as detailed in Section 6.3. Purification of the crude reaction solution proved
difficult and due to time constraints investigations into the production of PSIm were
halted. Due to the importance of NTPγS in research, the ability to produce them
via a simple and cost efficient method is essential, as such further investigations
into the production of PSIm should be carried out, with a view to use PSIm as a
thio-phosphoryl donor in the enzymatic production of NTPγSs by H122G NDPK .
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6 Experimental
6.1 General Instrumentation and Materials
The biological materials and buffer components were commercially available, all
solutions and buffers were prepared directly before use. The chemical syntheses
undertaken during the project, utilised raw commercial materials which did not
require further purification unless specifically stated.
NMR samples were prepared in deuterium oxide or with the use of a deuterium
oxide lock tube. 1H NMR spectra at 400.13 MHz and 31P NMR spectra at 161.98
MHz were recorded on Bruker Ultrashield 400, Varian Mercury 400 spectrometers in
Durham University. NMR data are represented as follows: chemical shift, integral,
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet),
coupling constants in Hertz (Hz), and assignment. The 31P NMR spectra presented
in section 6.3 have relaxation delays of 2.00 s, number of points for each spectrum
is 32768, spectral width is 49019.6 Hz and a limit of resolution of 1.49 Hz. The
1H NMR spectra presented in section 6.3 have relaxation delays of 1.00 s, number
of points for each spectrum is 32768, spectral width is 8012.8 Hz and a limit of
resolution of 0.24 Hz.
pH values (± 0.03) of buffered solutions were determined at 25 ◦C using a Meter-
Lab PHM 290 electrode, which was standardized for measurement between between
pH 4-7 or pH 7-12.46, depending on the pH of the buffered solution.
Moisture sensitive components were manipulated under an argon atmosphere
using glassware that had been dried over night at 95◦C.
6.2 Enzyme Expression
6.2.1 Protein Expression
The mutant NDPK H122G produced and overexpressed during this project was an
N-terminal fusion of H122G with a His6 tag (blue); with the following sequence:
MAHHHHHHSSGLEVLFQGP-MSTNKVNKERTFLAVKPDGVARGLVGEIIARYEKKGFVLVGLKQLVPTK
DLAESHYAEHKERPFFGGLVSFITSGPVVAMVFEGKGVVASARLMIGVTNPLASAPGSIRGDFGVDVGR
NIIGGSDSVESANREIALWFKPEELLTEVKPNPNLYE.
Four key steps were preformed during the expression of H122G NDPK mutant;
insert generation, linearisation of the expression vector, vector-insert annealing and
finally protein overexpression. Each of these steps will be discussed in subsections
below. Only protein overexpression was preformed by the author, the rest were
performed by Dr Freitag-Pohl but have been included for completeness.
6.2.1.1 Step 1: Insert Generation .
Synthetic pUC57 (cloning vector) plasmid, it was centrifuged at 6000 rpm at 4 ◦C
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for 1 minute, and then stored at - 20 ◦C. The plasmid and Stellar competent cells
were thawed before use. Plasmid (0.5 µL, 50 ng) was added to Stellar competent
cells (50 µL), the mixture was then incubated on ice for 30 minutes, then placed in
a water bath ( 42 ◦C ) for 45 seconds, before being returned to the ice box for 2
minutes. Warmed SOC media (450 µL, 37 ◦C ) was added to the competent cell/
plasmid solution, the mixture was then shaken at 200 rpm for 45 minutes at 37 ◦C.
Cell culture (50 µL) was added to fresh warmed SOC media (50 µL, 37 ◦C) and
grown on a LB/ agar plate. One colony from the plate was used to inoculate LB
media (10 ml LB + 10 µL ampicillin) and grown overnight at 37 ◦C, 5 ml of the
pre-culture was centrifuged at 5500 rpm for 2 minutes.
The pellet was resuspended in buffer (250 µL, 25 mM Tris-HCL pH 8, 10 mM
EDTA), after which alkaline lysis buffer(50 µL 400 mM NaOH, 50 µL 2 % SDS)
was added to the solution and mixed via inversion producing a viscous solution.
The lysate was neutralised with potassium acetate (5 M, pH 5.5), after which the
solution appeared cloudy. The solution was subjected to centrifugation at 14 000
rpm for 5 minutes, producing a white precipitate. The supernatant was loaded onto
a spin column and spun for 1 minute, the flow through was discarded. Wash solution
(500 µL) was added to the plasmid and then centrifuged again for 1 minute, the flow
through was discarded. Buffer (50 µL) was added to the plasmid, the mixture was
incubated at room temperature for 2 minutes before being centrifuged for 2 minutes
at 14 000 rpm, the isolated plasmid was stored at -20 ◦C.
PCR was preformed using CloneAmp HiFi PCR Premix, the PCR mix (25 µL)
was made up of the components shown in the table below.
Reagent Volume / µL
HiFi PCR Mix 12.5
Template 1
Forward Primer 2.5
Reverse Primer 2.5
DMSO 0.25
Water 6.25
.
The template used for PCR was the protein in the isolated pUC57, the for-
ward primer was 5’-AAGTTCTGTTTCAGGGCCCGATGTCCACAAATAAAGTAAACAAAG and the
reverse primer was 5’-ATGGTCTAGAAAGCTTTATTATTCGTATAAATTTGGGTTTGG. The tem-
perature cycle for PCR is displayed in the table below, a 14 ◦C gradient used during
step 3 annealing.
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Step Temperature / ◦C Time / s
1 - Initial Denaturation 98 60
2 - Denaturation 98 10
3 - Annealing 62 15
4 - Elongation 72 30
5 - Final Elongation 72 300
.
After amplification of the insert via PCR, the product was ran on a 1.5 % agarose
gel. A NucleoSpin Gel and PCR kit was used to extract the insert from the agarose
gel. The contents of the NucleoSpi kit are listed in the table below.
Reagent Volume / mL
Binding Buffer NT1 10
Wash Buffer NT3 6
Elution Buffer NE 13
.
Elution buffer (NE) was Tris/HCl (5 mM, pH 8.5), before use of the wash buffer
it was diluted with ethanol (24 ml).
The band containing the amplified insert was cut out of the agarose gel, the
gel (100 mg) was dissolved in NT1 buffer (200 µL). The sample was incubated for
10 minutes at 50 ◦C, vortexing briefly every 2 minutes until the gel had dissolved.
The sample was pippeted into a spin column and the volume made up to 700 µL
with NT1, the column was then centrifuged at 11 000 g for 30 seconds. The flow
through was discarded and buffer NT3 (700 µL) was added to the column, which was
again centrifuged at 11 000 g for 30 seconds. After washing with NT3 the column
was centrifuged at 11 000 g for 1 minute, elution buffer (15 µL) was added to the
sample and then incubated at room temperature for 1 minute. The sample was then
centrifuged for 1 minute at 11 000 g.
6.2.1.2 Step 2: Linearise Expression Vector .
Expression vector pOPINF was a bacterial stab, as such it was grown on a LB/agar
(with ampicillin) plate. One colony from the plate was used to inoculate LB media
(10 ml LB + 10 µL ampicillin) and grown overnight at 37 ◦C, 5 ml of the pre-culture
was centrifuged at 5500 rpm for 2 minutes.
The pellet was resuspended in buffer (250 µL, 25 mM Tris-HCL pH 8, 10 mM
EDTA), after which alkaline lysis buffer(50 µL 400 mM NaOH, 50 µL 2 % SDS)
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was added to the solution and mixed via inversion producing a viscous solution.
The lysate was neutralised with potassium acetate (5 M, pH 5.5), after which the
solution appeared cloudy. The solution was subjected to centrifugation at 14 000
rpm for 5 minutes, producing a white precipitate. The supernatant was loaded onto
a spin column and spun for 1 minute, the flow through was discarded. Wash solution
(500 µL) was added to the plasmid and then centrifuged again for 1 minute, the flow
through was discarded. Buffer (50 µL) was added to the plasmid, the mixture was
incubated at room temperature for 2 minutes before being centrifuged for 2 minutes
at 14 000 rpm, producing isolated pOPINF plasmids.
The isolated pOPINF plasmids were linearised via a double digest, the compo-
nents involved in the digest are detailed in the table below.
Reagent Volume / mL
pOPINF plasmid 22
HindIII 4
KpnI 1
10 × KpnI buffer 3
.
The product was shaken over night at 37 ◦C, and then ran on 15 % agarose gel
to confirm the presence of linear pOPINF. The band relating to linear pOPINF was
cut out of the gel and extracted using a NucleoSpin Gel and PCR kit, the same
method as used in section 6.2.1.1 was again used to extract the linear pOPINF from
the agarose gel.
6.2.1.3 Step 3: Vector - Insert Annealing .
The amplified and isolated insert (42 ng µL−1) generated in step 1 and the isolated
linear pOPINF vector (78.8 ng µL−1 ) were bound together using a vector to insert
ration of 1 : 2. The reaction components are detailed in the following table.
Reagent Volume / mL
linear pOPINF 2
insert 1
5× in-fusion enzyme 2
H2O 5
.
The solution was then incubated at 50 ◦C, for 15 minutes. The recombinant
plasmid was transformed into Stellar competent cells using the same method as
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described in section 6.2.1.1. Eight colonies were removed from the LB/agar plate
and mixed with LB/ ampicillin (50 µL), 1 µL of these mixture was then used as
a DNA template for PCR, using the temperature cycle below, without a gradient
during the annealing step.
Step Temperature / ◦C Time / s
1 - Initial Denaturation 98 60
2 - Denaturation 98 10
3 - Annealing 62 15
4 - Elongation 72 30
5 - Final Elongation 72 300
.
The PCR products of the eight colonies were ran on 15 % agarose gel, colonies
found to contain the 500 pb insert were used for overexpression of the protein.
6.2.1.4 Step 4: Protein Overexpression .
The recombinant plasmid was transformed into e.coli expression cells BL21(DE3).
Recombinant plasmid (1 µL) was added to competent BL21(DE3) cells (10 µL),
the resulting mixture was incubated on ice for 30 minutes, then a water bath (42
◦C) for 45 seconds which was followed by 2 minutes on ice. Warmed SOC media
(900 µL, 37 ◦C ) was added to the solution, which was then shaken (37 ◦C) at 200
rpm for 1 h. A LB/agar plate contaminating ampicillin and chloramphenicol was
inoculated with 150 µL of the mixture and grow overnight at 37 ◦C. The remaining
solution was centrifuged for 5 minutes at 6000 g, the pellet was resupended in SOC
media (150 µL) and grown overnight on a LB/agar plate contaminating ampicillin
and chloramphenicol at 37 ◦C.
Colonies from the plate were used to inoculate LB media (250 ml), which was
grown overnight at 37 ◦C. 40 ml of the overnight culture was added to LB (1 L)
with ampicillin (1 ml, 100 mg ml−1), and grown at 37 ◦C to an optical density of
0.7 The mixture was induced by IPTG (1 ml, 1M) and grown overnight at 20 ◦C.
The culture was centrifuges at 4000 rpm for 20 minutes and the pellet re-suspended
in lysis × binding buffer (50 ml) with a protease inhibitor tablet. Cells were then
lysed by sonication (cycle 2 × 10 % on ice for 2 minutes at 40 % power), before
undergoing centrifugation at 21000 rpm for 30 minutes.
6.2.2 Protein Purification
A HisTrap (1 ml) column was equilibrated with water, then with lysis × binding
buffer. The supernatant from the centrifuged lysate cells was loaded onto the His-
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Trap column. Purification of the enzyme required the use of two buffers; lysis ×
binding buffer and an elution buffer.
Components of the lysis × binding buffer are shown in the table below.
Reagent Concentration / mM
Tris-HCl pH 7.5 50
NaCl 500
imidazole 30
β-mercaptoethanol 2
.
Components of the elution buffer are shown in the table below.
Reagent Concentration / mM
Tris-HCl pH 7.5 50
NaCl 500
imidazole 1000
β-mercaptoethanol 2
.
Protein purification was carried out using an Amersham Biosciences A¨KTAprime
protein purification system, equipped with fraction collector. A¨KTA lines were
firstly washed with MilliQ water (18.2 Ω) then line A was purged with lysis +
binding buffer, line B was purged with elution buffer. The program washes the
column for 20 minutes, with 100 % lysis + binding buffer at a rate of 1 ml min−1.
After the column wash stage was completed the % of elution buffer was increased
from 0, 20 40, 60, 80 and 100 %, via a step up every 5 minutes, flow rate remained
at 1 ml min−1 and 2 ml were collected. The procedure was complete when 100%
elution buffer was passing through the column and no further protein was eluting.
Fractions which related to the signal on the chromatograph were kept for further
analysis.
6.2.2.1 Confirmation of NDPK H122G Purification .
Fractions of interest and samples from either end of the flow through, were analysed
via SDS-PAGE. Samples were boiled in loading buffer at 100 °C for 5 min to denature
the proteins, before being loaded on to the gel. After loading then gel was run in
1 × SDS-PAGE running buffer at 150 V until the dye-front reached the bottom of
the gel plate. After the gel had been run it was removed from the tank and washed
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with MilliQ water (18.2 Ω), after which it was covered with Coomassie Blue staining
solution. The gel was left in the Coomassie Blue solution with agitation for 30 min,
before the solution was decanted, destained and the gel was examined.
6.3 Chemical Synthesis
6.3.1 Synthesis of Phosphoimidazole 62
Imidazole (75) (0.51 g, 7.48 mmol) was dissolved in sodium hydroxide solution
(100 ml, 450 mM) under an inert nitrogen atmosphere. Dry acetonitrile (10 ml)
was added to phosphoryl chloride (72) (699 µL, 7.48 mmol) in a dropping funnel,
under an argon atmosphere. The phosphoryl chloride solution was added to the
imidazole solution via dropwise addition over 10 minutes, the reaction mixture was
then stirred vigorously for 1 h. The reaction mixture was then subjected to rotary
evaporation, which resulted in the formation of a white precipitate. The precipitate
and solution were then separated via centrifugation (4000 rpm, 10 minutes). The
precipitate was then recrystallised twice from sodium hydroxide (3 ml, 10 mM), after
which the precipitate was dried on the high vacuum line. Once dry, the crystals were
ground up before being subjected to overnight extraction with ethyl acetate (50 ml).
The crystals were then dried on the high vacuum line to yield the final product of
phosphoimidazole (62) (0.49 g, 44 %). δH(400 MHz; D2O-d2) 6.92 (1H, dd, J 4, 8),
7.16 (1H, dd,J 4, 8), 7.72 (1H, s) δP (162 MHz; D2O-d2) 4.42 (1P, s)
6.3.2 Synthesis of Potassium Thiophosphodichloridate 90
Thiophosphoryl chloride (1.410 g, 8.33 mmol) in dry acetonitrile (25 ml) was
added to oven-dried potassium hydrogen carbonate (1.675 g, 0.0167 mol), under
an argon atmosphere. The mixture was stirred for 12 h and, the potassium chlo-
ride by-product was removed via filtration, to give a final product solution of 0.33
M potassium thiophosphodichloridate in dry acetonitrile. Potassium thiophospho-
dichloridate 90 was freshly made and used immediately for the attempted synthesis
of thiophosphoimidazole. δP (162 MHz; D2O-d2) 39.8 (1P, s)
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6.3.3 Synthesis of Thiophosphoimidazole 91
Imidazole 75 (0.34 g, 4.99 mmol) was dissolved in sodium hydroxide solution (100
ml, 300 mM) in an inert nitrogen atmosphere. Potassium thiophosphodichloridate
90 in dry acetonitrile (15.15 ml, 0.33 M) was added to the imidazole solution via
dropwise addition over 10 minutes, the reaction mixture was then stirred vigorously
for three hours. The reaction mixture was then subjected to rotary evaporation,
which resulted in the formation of a off-white precipitate. The precipitate and
solution were then separated via centrifugation (4000 rpm, 10 minutes). The thio-
phosphoimidazole 91 proved difficult to purify further , as such the NMR is of the
crude material. δH(400 MHz; D2O-d2) 6.92 (1H, d,J 4 ), 7.25 (1H, dd,J 4, 8), 7.81
(1H, s) δP (162 MHz; D2O-d2) 34.6 (1P, s)
6.4 Enzyme Assay
6.4.1 Reactions involving Adenosine Nucleotides
Four series of studies involving either ADP (61) or ATP (16) as a substrate were
performed over the course of this project: dephosphorylation of 16, phosphorylation
of 61, effect of impurities on phosphorylation level/rate of 61 from crude phospho-
imidazole 62 and effect of 62 concentration on level/rate of conversion to 16 (from
purified 62), the protocol for each of these reactions will be discussed in detail. All
references to HEPES reaction buffer are referencing the buffer detailed in the table
below.
Reagent Concentration / mM
HEPES 30
MgCl2 10
NaCl 150
.
HEPES buffer was made by combining 1 ml of HEPES (300 mM, pH 7.5), with
1ml MgCl2 (100 mM) and 1 ml of NaCl (1.5 M), 6 ml Milli Q (18.2 Ω) was then
added to the solution. The pH was then monitored and adjusted to pH 7.5 using
HCl or NaOH as required, the total volume of the HEPES stock solution was 10 ml.
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6.4.1.1 Dephosphorylation of 16 .
16 (5 µL, 100 mM) and imidazole (75) (1 ml, 30 mM, pH 7.5) were added to HEPES
reaction buffer (1 ml, pH 7.5). H122G NDPK (2 µL, 9.5 mg ml−1) was then added
to the reaction solution, which was then inverted to ensure mixing of all reaction
components. Immediately after inversion, a 100 µL sample was taken, and then 100
µL samples were taken at time points of; 0, 15, 60 and 90 minutes. The samples
were subjected to centrifugation at 13.5 rpm for 15 minutes in an Amicon Ultra-0.5
Centrifugal Filter Unit (10 kDa), to allow for the removal of H122G enzyme from
each sample. The samples were then subjected to HPLC analysis.
6.4.1.2 Phosphorylation of 61 from 62 .
Phosphoimidazole (62) (75 mg, 0.5 mmol) was added to HEPES reaction buffer
(1 ml, pH 7.5) the pH was then adjusted back to 7.5 with HCl (37 %). 61 (5
µL, 100 mM) was then added to the reaction solution along with H122G NDPK (2
µL, 9.5 mg ml−1), the solution was then inverted to ensure mixing of all reaction
components. Immediately after inversion, a 100 µL sample was taken, and then 100
µL samples were taken at time points of; 0, 15, 60 and 90 minutes. The samples
were subjected to centrifugation at 13.5 rpm for 15 minutes in Amicon Ultra-0.5
Centrifugal Filter Unit (10 kDa), to allow for the removal of H122G enzyme from
the sample. The samples were then subjected to HPLC analysis.
6.4.1.3 Effect of Impurities on Phosphorylation of 61 .
Crude 62 reaction mixture was subjected to rotary evaporation, which resulted in
the removal of acetonitrile, giving a clear colourless crude solution of 62. The pH
of the crude 62 was adjusted from 10.76 to 7.51 using HCl (0.5 M). Three reactions
were done in parallel using this crude 62 solution. All of the reactions used the
same basic reagent composition: crude 62 (2.02 mL), HEPES reaction buffer (1
mL, pH 7.5), textcolorblack61 (5 µL, 100 mM). MilliQ water (18.2 Ω, 0.5 mL),
75 (30 mM, 0.5 mL, pH 7.5) or acetonitrile (0.5 ml) were then added to reactions;
textcolorblackVII, textcolorblackVIII and textcolorblackIX respectively. H122G
NDPK (2 µL, 9.5 mg ml−1) was then added to each of the reaction solutions, which
were then inverted to ensure mixing of all reaction components. 100 µL samples were
taken at time points of; 10, 30, 60, 90 and 120 minutes. The samples were subjected
to centrifugation at 13.5 rpm for 15 minutes in Amicon Ultra-0.5 Centrifugal Filter
Unit (10 kDa), to allow for the removal of H122G enzyme from the sample. The
samples were then subjected to HPLC analysis.
6.4.1.4 Effect of [62] on Degree of Conversion to 16 .
Purified 62 (0.1920 g) was dissolved in MilliQ water (18.2 Ω, 8 mL) and the pH
adjusted to 7.5 with HCl (37 %), MilliQ water was then added to give a total 62
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stock solution (100 mM) of volume 10 ml. All experiments used this common 62
stock solution. The volumes used in each of the four reactions are detailed in the
table below.
Reaction [62] / mM Volume of 62 stock / µL Volume of Water / µL
5 100 900
10 200 800
20 400 600
50 1000 0
.
All four of the reactions had the same basic procedure, firstly the 62 and water
were added to a 15 mL falcon tube, then HEPES reaction buffer (989 µL, pH 7.5)
and 61 ( 100 mM, 5 µL) were added. H122G NDPK (6 µL, 3.6 mg ml−1) was
then added to the reaction solution, which was then inverted to ensure mixing of
all reaction components. Immediately after inversion, a 100 µL sample was taken
and quenched with Na-EDTA (15 µL, pH 7.5). 100 µL samples were then taken
and quenched with Na-EDTA at time points of; 0, 5, 10, 15, 20, 25, 30, 35, 40, 45,
50, 55, 60, 90, 120, 180, 240, 300 and 1440 minutes. The samples were subjected
to centrifugation at 13.5 rpm for 15 minutes in Amicon Ultra-0.5 Centrifugal Filter
Unit (10 kDa), to allow for the removal of H122G enzyme from the sample. The
samples were then subjected to HPLC analysis.
6.4.2 Bioluminescent Assays
Two distinct bioluminescent reactions were carried out by Dr Hodgson using a
Molecular Probes/Invitrogen 16 detection kit (A22066), all reactions consisted of
one positive control experiment and four negative control experiments. The test kit
contained; D-luciferin (88)(3 mg), luciferase (5 mg ml−1), dithiothreitol, 16 (5 mM)
and 20× reaction buffer (500 mM Tricine buffer, pH 7.8, 100 mM MgSO4, 2 mM
EDTA and 2 mM sodium azide). Stock solutions of 88 (1 ml, 10 mM) and dithio-
threitol (1.62 ml, 100 mM) were made. A standard reaction solution (10 ml) was
made according to the manufactures instructions, the dithiothreitol and 88 stock
solutions were used, components of the standard reaction solution are displayed in
the table below.
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Reagent Volume / mL
H2O 8.9
20× reaction buffer 0.5
Dithiothreitol 0.1
D-luciferin 0.5
Luciferase 0.0025
.
The 16 test kit was calibrated as per the suppliers instructions, by adding 10
µL of 5 µM, 0.5 µM, 50 nM, 5 nM and 0.5 nM to 100 µL of the assembled standard
reaction solution. All concentrations, except 0.5 nM which appears to give a signal
below the background level of our instrument, gave a proportional luminescent re-
sponse. All experiments were carried out in the wells of a black-bodied microtiter
plate at 28 °C. Standard stock solutions of NDPK H122G (0.2 mg ml−1), crude 62
and were used throughout the experiments.
All experiments were performed in a black bodied microtiter plate, using stan-
dard reaction solution (100 µL). Reaction XII used 100 mM 61 (µL), 1 µL crude
62 and 1 µL NDPK H122G (0.2 mg ml−1). Reaction XIII used 1 mM 61 (µL), 4
µL crude 62 and 1 µL NDPK H122G (0.2 mg ml−1).
The luminescence signal was measured every minute for the first ten minutes after
initiation, both reactions were then stored overnight at 4 (◦)C, the reaction solutions
were allowed to warm to room temperature then luminescence was measured again
at a single time point.
6.5 HPLC Conditions and Retention Times
This section will firstly describe the protocol for the preparation of the eluent buffers
used throughout the project, then there will be an in-depth description of the pa-
rameters used for both of the columns and results of HPLC analysis.
A PerkinElmer Series 200 HPLC system was used for all of the kinetic experi-
ments analysed through HPLC. TotalChrom Chromatography sofware from PerkinElmer
was used to process the chromatographs on Microsoft Windows XP. The SUPELCOSIL-
18-T and SIELC-Primesep SB columns were pruchased from Sigma-Aldrich and
SIECL, respectively.
6.5.1 Buffer Preparation
A variety of elution buffers were required for the analysis of the nucleotides on the
two columns. Phosphate buffers were used for the elution of adenosine nucleotides,
while ammonium acetate buffers were utilised for the guanosine series.
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6.5.1.1 General Procedure for Phosphate Buffers .
A gradient elution method requiring two phosphate buffers, adapted from the lit-
erature procedure, was used for the elution of the adenosine series.68 buffer A -
KH2PO4, 0.1 M, pH = 6.00, buffer B - 90 % buffer A : 10 % methanol, pH = 6.00 .
6.5.1.1.1 Buffer A .
KH2PO4 (13.6 g) was dissolved in ∼ 900 ml MilliQ water (18.2 Ω), the pH of
the buffer was then adjusted from 4.55 to 6.00 through the addition of potassium
hydroxide solution (5 M). The total volume was made up to the 1 L mark in a
volumetric flask. The buffer was then vacuum filtered.
6.5.1.1.2 Buffer B .
The preparation of buffer B follows that of A, until filtration, methanol (100 ml)
was added to a 1 L volumetric flask which was then made up to the 1 L mark with
buffer A, to give a total volume of 1 L. The buffer was then vacuum filtered.
6.5.1.2 General Procedure for Acetate Buffers .
The guanosine series used two ammonium acetate based buffers to elute the nu-
cleotides. Buffer C (30 mM ammonium acetate, 5 % acetonitrile, pH 4.50) and
buffer D (200 mM ammonium acetate, 5 % acetonitrile, pH 4.50).
6.5.1.2.1 Buffer C .
Ammonium acetate (2.31 g) was dissolved in ∼ 800 ml of MilliQ water (18.2 Ω), the
pH was adjusted to 4.50 with glacial acetic acid. Acetonitrile (50 ml) was pipetted
into a 1 L volumetric flask and the ammonium acetate solution was added, the flask
was then topped up to 1 L with water, after which buffer C was filtered.
6.5.1.2.2 Buffer D .
Ammonium acetate (15.42 g) was dissolved in ∼ 800 ml of MilliQ water (18.2 Ω), the
pH was adjusted to 4.50 with glacial acetic acid. Acetonitrile (50 ml) was pipetted
into a 1 L volumetric flask and the ammonium acetate solution was added, the flask
was then topped up to 1 L with water, after which buffer D was filtered.
6.5.2 SUPELCOSIL-LC-18-T Column Protocol
Experiments involving adenosine nucleotides were completed, with a SUPELCOSIL-
LC-18-T column measuring 250 mm in length and 46 mm in diameter, surface
coverage 3.1 µmol m−2, matrix silica gel (spherical particle platform), particle size
5 µm and a surface area of 170 m2 g−1. The parameters and elution method below,
were used for all HPLC analysis performed on the SUPELCOSIL-LC-18-T column.
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Parameter Value Unit
Injection Volume 10 µL
Detector 254 nm
.
Step Time / min Flow /mlmin−1 % A % B Curve
0 6 1.3 100 0 0
1 9 1.3 100 0 0
2 4 1.3 0 100 1
3 4 1.3 0 100 0
4 1.5 1.3 100 0 1
.
Compound Retention Time / min
ATP 5.5
ADP 6.8
AMP 12.0
.
6.5.3 SIELC-Primesep SB Column Protocol
Experiments involving guanosine nucleotides were completed, with a SIELC-Primesep
SB column measuring 150 mm in length and 4.6 mm in diameter, particle size 5 µm.
The parameters and elution method below, were used for all HPLC analysis per-
formed on the SIELC-Primesep SB column.
The column was found to be very prone shifting peak retention time subsequently,
a cleaning step was added in to the protocol, running at 40 % acetonitrile and 60 %
buffer C.
Parameter Value Unit
Injection Volume 10 µL
Detector 254 nm
.
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Step Time / min Flow /mlmin−1 % C % D ACN Curve
0 5 1 70 30 0 0
1 30 1 0 100 0 1
2 5 1 0 100 0 0
3 5 1 70 0 30 1
4 15 1 60 0 40 1
5 5 1 70 30 0 1
6 5 1 70 30 0 0
.
Compound Retention Time / min
GDP 10
GTP 22
.
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